1
|
Trivieri MG, Robson PM, Vergani V, LaRocca G, Romero-Daza AM, Abgral R, Devesa A, Azoulay LD, Karakatsanis NA, Parikh A, Panagiota C, Palmisano A, DePalo L, Chang HL, Rothstein JH, Fayad RA, Miller MA, Fuster V, Narula J, Dweck MR, Morgenthau A, Jacobi A, Padilla M, Kovacic JC, Fayad ZA. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis. JACC Cardiovasc Imaging 2024; 17:411-424. [PMID: 38300202 DOI: 10.1016/j.jcmg.2023.11.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Revised: 11/14/2023] [Accepted: 11/20/2023] [Indexed: 02/02/2024]
Abstract
BACKGROUND Imaging with late gadolinium enhancement (LGE) magnetic resonance (MR) and 18F-fluorodeoxyglucose (18F-FDG) PET allows complementary assessment of myocardial injury and disease activity and has shown promise for improved characterization of active cardiac sarcoidosis (CS) based on the combined positive imaging outcome, MR(+)PET(+). OBJECTIVES This study aims to evaluate qualitative and quantitative assessments of hybrid MR/PET imaging in CS and to evaluate its association with cardiac-related outcomes. METHODS A total of 148 patients with suspected CS underwent hybrid MR/PET imaging. Patients were classified based on the presence/absence of LGE (MR+/MR-), presence/absence of 18F-FDG (PET+/PET-), and pattern of 18F-FDG uptake (focal/diffuse) into the following categories: MR(+)PET(+)FOCAL, MR(+)PET(+)DIFFUSE, MR(+)PET(-), MR(-)PET(+)FOCAL, MR(-)PET(+)DIFFUSE, MR(-)PET(-). Further analysis classified MR positivity based on %LGE exceeding 5.7% as MR(+/-)5.7%. Quantitative values of standard uptake value, target-to-background ratio, target-to-normal-myocardium ratio (TNMRmax), and T2 were measured. The primary clinical endpoint was met by the occurrence of cardiac arrest, ventricular tachycardia, or secondary prevention implantable cardioverter-defibrillator (ICD) before the end of the study. The secondary endpoint was met by any of the primary endpoint criteria plus heart failure or heart block. MR/PET imaging results were compared between those meeting or not meeting the clinical endpoints. RESULTS Patients designated MR(+)5.7%PET(+)FOCAL had increased odds of meeting the primary clinical endpoint compared to those with all other imaging classifications (unadjusted OR: 9.2 [95% CI: 3.0-28.7]; P = 0.0001), which was higher than the odds based on MR or PET alone. TNMRmax achieved an area under the receiver-operating characteristic curve of 0.90 for separating MR(+)PET(+)FOCAL from non-MR(+)PET(+)FOCAL, and 0.77 for separating those reaching the clinical endpoint from those not reaching the clinical endpoint. CONCLUSIONS Hybrid MR/PET image-based classification of CS was statistically associated with clinical outcomes in CS. TNMRmax had modest sensitivity and specificity for quantifying the imaging-based classification MR(+)PET(+)FOCAL and was associated with outcomes. Use of combined MR and PET image-based classification may have use in prognostication and treatment management in CS.
Collapse
Affiliation(s)
- Maria Giovanna Trivieri
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
| | - Philip M Robson
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Vittoria Vergani
- School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK
| | - Gina LaRocca
- Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | | | - Ronan Abgral
- Department of Nuclear Medicine, University Hospital of Brest, European University of Brittany, Brest, France
| | - Ana Devesa
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Levi-Dan Azoulay
- Sorbonne Université, INSERM, CNRS, Laboratoire d'Imagerie Biomédicale (LIB), Paris, France
| | - Nicolas A Karakatsanis
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Division of Radiopharmaceutical Sciences, Department of Radiology, Weill Cornell Medical College, New York, New York, USA
| | - Aditya Parikh
- Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Christia Panagiota
- Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Anna Palmisano
- Experimental Imaging Center, Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Louis DePalo
- Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Helena L Chang
- International Center for Health Outcomes and Innovation Research, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Joseph H Rothstein
- International Center for Health Outcomes and Innovation Research, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Rima A Fayad
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Marc A Miller
- Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Valentin Fuster
- Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Jagat Narula
- Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Marc R Dweck
- British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, Scotland, UK
| | - Adam Morgenthau
- Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Adam Jacobi
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Maria Padilla
- Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Jason C Kovacic
- Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Victor Chang Cardiac Research Institute and St Vincent's Clinical School, University of NSW, Darlinghurst, New South Wales, Australia
| | - Zahi A Fayad
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| |
Collapse
|
2
|
Devesa A, Rashed E, Moss N, Robson PM, Pyzik R, Roldan J, Taimur S, Rana MM, Ashley K, Young A, Patel G, Mahmood K, Mitter SS, Lala A, Barghash M, Fox A, Correa A, Pirlamarla P, Contreras J, Parikh A, Mancini D, Jacobi A, Ghesani N, Gavane SC, Ghesani M, Itagaki S, Anyanwu A, Fayad ZA, Trivieri MG. 18F-FDG PET/CT in left ventricular assist device infections: In-depth characterization and clinical implications. J Heart Lung Transplant 2024; 43:529-538. [PMID: 37951322 DOI: 10.1016/j.healun.2023.11.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2023] [Revised: 10/09/2023] [Accepted: 11/06/2023] [Indexed: 11/13/2023] Open
Abstract
BACKGROUND Previous retrospective studies suggest a good diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET)/computed tomography (CT) in left ventricular assist device (LVAD) infections. Our aim was to prospectively evaluate the role of PET/CT in the characterization and impact on clinical management of LVAD infections. METHODS A total of 40 patients (aged 58 [53-62] years) with suspected LVAD infection and 5 controls (aged 69 [64-71] years) underwent 18F-FDG-PET/CT. Four LVAD components were evaluated: exit site and subcutaneous driveline (peripheral), pump pocket, and outflow graft. The location with maximal uptake was considered the presumed site of infection. Infection was confirmed by positive culture (exit site or blood) and/or surgical findings. RESULTS Visual uptake was present in 40 patients (100%) in the infection group vs 4 (80%) control subjects. For each individual component, the presence of uptake was more frequent in the infection than in the control group. The location of maximal uptake was most frequently the pump pocket (48%) in the infection group and the peripheral components (75%) in the control group. Maximum standard uptake values (SUVmax) were higher in the infection than in the control group: SUVmax (average all components): 6.9 (5.1-8.5) vs 3.8 (3.7-4.3), p = 0.002; SUVmax (location of maximal uptake): 10.6 ± 4.0 vs 5.4 ± 1.9, p = 0.01. Pump pocket infections were more frequent in patients with bacteremia than without bacteremia (79% vs 31%, p = 0.011). Pseudomonas (32%) and methicillin-susceptible Staphylococcus aureus (29%) were the most frequent pathogens and were associated with pump pocket infections, while Staphylococcus epidermis (11%) was associated with peripheral infections. PET/CT affected the clinical management of 83% of patients with infection, resulting in surgical debridement (8%), pump exchange (13%), and upgrade in the transplant listing status (10%), leading to 8% of urgent transplants. CONCLUSIONS 18F-FDG-PET/CT enables the diagnosis and characterization of the extent of LVAD infections, which can significantly affect the clinical management of these patients.
Collapse
Affiliation(s)
- Ana Devesa
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Mount Sinai Fuster Heart Hospital, New York, New York; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
| | - Eman Rashed
- Mount Sinai Fuster Heart Hospital, New York, New York
| | - Noah Moss
- Mount Sinai Fuster Heart Hospital, New York, New York
| | - Philip M Robson
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Renata Pyzik
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Julie Roldan
- Mount Sinai Fuster Heart Hospital, New York, New York
| | - Sarah Taimur
- Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Meenakshi M Rana
- Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Kimberly Ashley
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Anna Young
- Mount Sinai Fuster Heart Hospital, New York, New York
| | - Gopi Patel
- Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Kiran Mahmood
- Mount Sinai Fuster Heart Hospital, New York, New York
| | | | - Anuradha Lala
- Mount Sinai Fuster Heart Hospital, New York, New York
| | - Maya Barghash
- Mount Sinai Fuster Heart Hospital, New York, New York
| | - Arieh Fox
- Mount Sinai Fuster Heart Hospital, New York, New York
| | - Ashish Correa
- Mount Sinai Fuster Heart Hospital, New York, New York
| | | | | | - Aditya Parikh
- Mount Sinai Fuster Heart Hospital, New York, New York
| | - Donna Mancini
- Mount Sinai Fuster Heart Hospital, New York, New York
| | - Adam Jacobi
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Nasrin Ghesani
- Division of Nuclear Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Somali C Gavane
- Division of Nuclear Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Munir Ghesani
- Division of Nuclear Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Shinobu Itagaki
- Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Anelechi Anyanwu
- Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Zahi A Fayad
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Maria Giovanna Trivieri
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Mount Sinai Fuster Heart Hospital, New York, New York.
| |
Collapse
|
3
|
Xu D, de la Hoz RE, Steinberger SR, Doucette J, Pagano AM, Wolf A, Chung M, Jacobi A. Postoperative CT surveillance in the evaluation of local recurrence after sub-lobar resection of neoplastic lesions of the lung. Clin Imaging 2024; 106:110030. [PMID: 38150854 DOI: 10.1016/j.clinimag.2023.110030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2023] [Revised: 11/03/2023] [Accepted: 11/13/2023] [Indexed: 12/29/2023]
Abstract
OBJECTIVE As indications for sub-lobar resections increase, it will become more important to identify risk factors for postsurgical recurrence. We investigated retrospectively the association between local recurrence after sub-lobar resection of neoplastic lung lesions and pre- and post-operative CT imaging and pathologic features. MATERIALS AND METHODS We reviewed retrospectively neoplastic lung lesions with postoperative chest CT surveillance of sub-lobar resections in 2006-2016. We defined "suspicious" findings as nodularity ≥3 mm or soft tissue thickening ≥4 mm along the suture line and/or progression and explored their association with local recurrence. Primary lung cancer stage, tumoral invasion of lymphatics, visceral pleura or large vessels, bronchial and vascular margin distance were also assessed. RESULTS Our study group included 45 cases of sub-lobar resection took for either primary (n = 37) or metastatic (n = 8) lung tumors. Local recurrence was observed in 16 of those patients. New nodularity ≥3 mm or soft tissue thickening ≥4 mm along the suture line on surveillance CT was significantly associated with local recurrence (p = 0.037). Additionally, solid nodule (p = 0.005), age at surgery ≤60 years (p = 0.006), two or more sites of invasion (p < 0.0001) and poor histologic differentiation (p = 0.0001) were also significantly associated with local tumor recurrence. Of 16 patients with surveillance post-surgical PET-CT, 15 had elevated FDG uptake. CONCLUSION The postoperative changes along the suture line should follow a predictable time course demonstrating a pattern of stability, thinning or resolution on CT surveillance. New or increasing postoperative nodularity ≥3 mm or soft tissue thickening ≥4 mm along the suture line requires close diagnostic work-up. Surgical pathology characteristics added prognostic value on postoperative recurrence surveillance.
Collapse
Affiliation(s)
- Dongming Xu
- University of Pennsylvania, Radiology, 3400 Spruce Street, Philadelphia, PA 19104, USA.
| | - Rafael E de la Hoz
- Departments of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | | | - John Doucette
- Icahn School of Medicine at Mount Sinai, Environmental Medicine and Public Health, One Gustave L. Levy Place, New York, NY 10029, USA
| | - Andrew Michael Pagano
- Memorial Sloan Kettering Cancer Center, Radiology, 1275 York Ave., New York, NY 10065, USA
| | - Andrea Wolf
- Icahn School of Medicine at Mount Sinai, Thoracic Surgery, One Gustave L. Levy Place, New York, NY 10029, USA
| | - Michael Chung
- Icahn School of Medicine at Mount Sinai, Department of Radiology, One Gustave L. Levy Place, New York, NY 10029, USA
| | - Adam Jacobi
- Icahn School of Medicine at Mount Sinai, Department of Radiology, One Gustave L. Levy Place, New York, NY 10029, USA
| |
Collapse
|
4
|
Hotca AE, Jacobi A, Bloom JR, Hsieh K, Cherry DR, Sheu R, Runnels J, Moshier E, Fu W, Sahni G, Goodman KA. The Role of Coronary Artery Calcium Score to Assess Risk of Cardiovascular Disease in Irradiated Esophageal Cancer Patients. Int J Radiat Oncol Biol Phys 2023; 117:e302. [PMID: 37785103 DOI: 10.1016/j.ijrobp.2023.06.2319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Coronary artery calcium (CAC) score is an important predictive imaging marker of cardiovascular disease (CVD). While studies have found positive association between CAC score and cardiac toxicity in irradiated lung and breast cancer patients, there are no studies assessing CAC scores in esophageal cancer (EC). While a cardiac-gated CT is required for standard Agatston CAC score, visual assessment of CAC via ordinal scoring on non-gated CT has shown good concordance with Agatston score. In this study, we sought to examine whether visual assessment of CAC, measured on standard of care, non-contrast chest CT, predicts the development of adverse cardiovascular events (ACVE) in irradiated EC patients. MATERIALS/METHODS This is a single institution retrospective study of EC patients treated with RT from 2010-2021. We included patients with available PET/CT at diagnosis or chest CT simulation scan without contrast, and excluded those with history of percutaneous coronary intervention, coronary bypass surgery, or prior thoracic RT. Pre-treatment characteristics, clinical factors, and grade ≥ 3 (G3+) adverse cardiovascular events (ACVE) (CTCAEv5.0) were evaluated. Visual assessment of CAC was performed using ordinal method (CAC scored from 0 to 12), by a thoracic radiologist. Fine and Gray regression was used to compute hazard ratios for time to first ACVE. Univariate analyses using Cox proportional hazards were used for overall survival (OS). ACVEs were recorded from start of oncologic treatment and OS calculated after completion of RT. RESULTS A total of 118 patients were analyzed with a median follow-up of 16 months. Median age was 67 years, 65% male, 43% white, 59% with EC of distal esophagus, and 59% had squamous cell carcinoma. Median mean heart dose was 21.93 Gy (range 0.15-36.94). 24% developed G3+ ACVEs: atrial fibrillation 9%, stroke 6%, heart failure 4%, pulmonary embolism 4%, pericardial effusion 3%, myocardial infarction 2%, heart block 2%, and cardiac death 1%. On univariate analyses, CAC >1 vs. CAC ≤ 1 trended towards increased risk of ACVE (HR = 1.95, 95% CI = 0.89-4.26; p = 0.094), however it is not predictive of OS (HR = 1.31, 95% CI = 0.75-2.30; p = 0.343). Proportion of patients with ACVEs was greater in CAC>1 group (Table). When compared to patients with CAC ≤ 1, those with CAC >1 were older (median age 62 vs 72 years, p = 0.0015), less likely to be never smokers (38% vs 30%, p = 0.0437), and more likely to have hypertension (43% vs 64%, p = 0.0197), and hyperlipidemia (30% vs 47%, p = 0.0557). CONCLUSION This is the first study to investigate the relationship between CAC score and ACVEs in EC. While the study was underpowered (likely due to low rates of recorded ACVEs), to detect a significant association between CAC score and ACVEs, there was a trend towards increased risk of ACVEs in patients with a CAC score >1 by visual ordinal scoring. Further prospective evaluation with a larger cohort is warranted.
Collapse
Affiliation(s)
- A E Hotca
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
| | - A Jacobi
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY
| | - J R Bloom
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
| | - K Hsieh
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
| | - D R Cherry
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
| | - R Sheu
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
| | - J Runnels
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
| | - E Moshier
- Icahn School of Medicine at Mount Sinai, Department of Population Health Science & Policy, New York, NY
| | - W Fu
- Icahn School of Medicine at Mount Sinai, Department of Population Health Science & Policy, New York, NY
| | - G Sahni
- Cardiology Division, Icahn School of Medicine at Mount Sinai, New York, NY
| | - K A Goodman
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
| |
Collapse
|
5
|
Devesa A, Robson PM, Pyzik R, Jacobi A, Ghesani M, Anyanwu A, Mancini D, Fayad ZA, Trivieri MG. 68Ga-Dotatate Hybrid Positron Emission Tomography/Magnetic Resonance Imaging for Noninvasive Early Detection of Heart Transplant Rejection. Circ Cardiovasc Imaging 2023; 16:e015282. [PMID: 37212179 PMCID: PMC10442064 DOI: 10.1161/circimaging.123.015282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Affiliation(s)
- Ana Devesa
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY
- Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
- Zena and Michael A. Weiner Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Philip M. Robson
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Renata Pyzik
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Adam Jacobi
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Munir Ghesani
- Division of Nuclear Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Anelechi Anyanwu
- Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Donna Mancini
- Zena and Michael A. Weiner Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Zahi A. Fayad
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Maria Giovanna Trivieri
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY
- Zena and Michael A. Weiner Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY
| |
Collapse
|
6
|
Yang A, Jacob JC, DeMarco C, Marcadis P, Chung M, Jacobi A. Postoperative imaging of thoracic aortic repairs. Clin Imaging 2023; 101:8-21. [PMID: 37262963 DOI: 10.1016/j.clinimag.2023.05.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Revised: 05/05/2023] [Accepted: 05/22/2023] [Indexed: 06/03/2023]
Abstract
Imaging plays a crucial role in the postoperative monitoring of thoracic aortic repairs. With the development of multiple surgical techniques to repair the ascending aorta and aortic arch, it can be a daunting challenge for the radiologist to diagnose potential pathologies in this sea of various techniques, each with their own normal postoperative appearance and potential complications. In this paper, we will provide a comprehensive review of the postoperative imaging in the setting of thoracic aortic repairs, including the role of imaging, components of thoracic aortic repairs, the normal postoperative appearance, and potential complications.
Collapse
Affiliation(s)
- Anthony Yang
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, United States of America.
| | - Julia C Jacob
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Cody DeMarco
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Philip Marcadis
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Michael Chung
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Adam Jacobi
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, United States of America
| |
Collapse
|
7
|
Lange M, Boddu P, Singh A, Gross BD, Mei X, Liu Z, Bernheim A, Chung M, Huang M, Masseaux J, Dua S, Platt S, Sivakumar G, DeMarco C, Lee J, Fayad ZA, Yang Y, Padilla M, Jacobi A. Influence of thoracic radiology training on classification of interstitial lung diseases. Clin Imaging 2023; 97:14-21. [PMID: 36868033 DOI: 10.1016/j.clinimag.2022.12.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Revised: 12/07/2022] [Accepted: 12/27/2022] [Indexed: 01/03/2023]
Abstract
INTRODUCTION Interpretation of high-resolution CT images plays an important role in the diagnosis and management of interstitial lung diseases. However, interreader variation may exist due to varying levels of training and expertise. This study aims to evaluate interreader variation and the role of thoracic radiology training in classifying interstitial lung disease (ILD). METHODS This is a retrospective study where seven physicians (radiologists, thoracic radiologists, and a pulmonologist) classified the subtypes of ILD of 128 patients from a tertiary referral center, all selected from the Interstitial Lung Disease Registry which consists of patients from November 2014 to January 2021. Each patient was diagnosed with a subtype of interstitial lung disease by a consensus diagnosis from pathology, radiology, and pulmonology. Each reader was provided with only clinical history, only CT images, or both. Reader sensitivity and specificity and interreader agreements using Cohen's κ were calculated. RESULTS Interreader agreement based only on clinical history, only on radiologic information, or combination of both was most consistent amongst readers with thoracic radiology training, ranging from fair (Cohen's κ: 0.2-0.46), moderate to almost perfect (Cohen's κ: 0.55-0.92), and moderate to almost perfect (Cohen's κ: 0.53-0.91) respectively. Radiologists with any thoracic training showed both increased sensitivity and specificity for NSIP as compared to other radiologists and the pulmonologist when using only clinical history, only CT information, or combination of both (p < 0.05). CONCLUSIONS Readers with thoracic radiology training showed the least interreader variation and were more sensitive and specific at classifying certain subtypes of ILD. SUMMARY SENTENCE Thoracic radiology training may improve sensitivity and specificity in classifying ILD based on HRCT images and clinical history.
Collapse
Affiliation(s)
- Marcia Lange
- Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Priyanka Boddu
- Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Ayushi Singh
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Benjamin D Gross
- Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Xueyan Mei
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Zelong Liu
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Adam Bernheim
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Michael Chung
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Mingqian Huang
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Joy Masseaux
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Sakshi Dua
- Department of Medicine, Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Samantha Platt
- Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Ganesh Sivakumar
- Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Cody DeMarco
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Justine Lee
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Zahi A Fayad
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America; BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Yang Yang
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Maria Padilla
- Department of Medicine, Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America
| | - Adam Jacobi
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America.
| |
Collapse
|
8
|
Mei X, Liu Z, Singh A, Lange M, Boddu P, Gong JQX, Lee J, DeMarco C, Cao C, Platt S, Sivakumar G, Gross B, Huang M, Masseaux J, Dua S, Bernheim A, Chung M, Deyer T, Jacobi A, Padilla M, Fayad ZA, Yang Y. Interstitial lung disease diagnosis and prognosis using an AI system integrating longitudinal data. Nat Commun 2023; 14:2272. [PMID: 37080956 PMCID: PMC10119160 DOI: 10.1038/s41467-023-37720-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2022] [Accepted: 03/29/2023] [Indexed: 04/22/2023] Open
Abstract
For accurate diagnosis of interstitial lung disease (ILD), a consensus of radiologic, pathological, and clinical findings is vital. Management of ILD also requires thorough follow-up with computed tomography (CT) studies and lung function tests to assess disease progression, severity, and response to treatment. However, accurate classification of ILD subtypes can be challenging, especially for those not accustomed to reading chest CTs regularly. Dynamic models to predict patient survival rates based on longitudinal data are challenging to create due to disease complexity, variation, and irregular visit intervals. Here, we utilize RadImageNet pretrained models to diagnose five types of ILD with multimodal data and a transformer model to determine a patient's 3-year survival rate. When clinical history and associated CT scans are available, the proposed deep learning system can help clinicians diagnose and classify ILD patients and, importantly, dynamically predict disease progression and prognosis.
Collapse
Affiliation(s)
- Xueyan Mei
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
| | - Zelong Liu
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Ayushi Singh
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Marcia Lange
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Priyanka Boddu
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Jingqi Q X Gong
- Department of Pharmaceutical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Justine Lee
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Cody DeMarco
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Chendi Cao
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Samantha Platt
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | | | - Benjamin Gross
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Mingqian Huang
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Joy Masseaux
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Sakshi Dua
- Department of Medicine, Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Adam Bernheim
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Michael Chung
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Timothy Deyer
- Department of Radiology, Cornell Medicine, New York, NY, USA
- Department of Radiology, East River Medical Imaging, New York, NY, USA
| | - Adam Jacobi
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Maria Padilla
- Department of Medicine, Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Zahi A Fayad
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
| | - Yang Yang
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.
| |
Collapse
|
9
|
Fauveau V, Jacobi A, Bernheim A, Chung M, Benkert T, Fayad ZA, Feng L. Performance of spiral UTE-MRI of the lung in post-COVID patients. Magn Reson Imaging 2023; 96:135-143. [PMID: 36503014 PMCID: PMC9731813 DOI: 10.1016/j.mri.2022.12.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2022] [Revised: 11/18/2022] [Accepted: 12/01/2022] [Indexed: 12/13/2022]
Abstract
Patients recovered from COVID-19 may develop long-COVID symptoms in the lung. For this patient population (post-COVID patients), they may benefit from longitudinal, radiation-free lung MRI exams for monitoring lung lesion development and progression. The purpose of this study was to investigate the performance of a spiral ultrashort echo time MRI sequence (Spiral-VIBE-UTE) in a cohort of post-COVID patients in comparison with CT and to compare image quality obtained using different spiral MRI acquisition protocols. Lung MRI was performed in 36 post-COVID patients with different acquisition protocols, including different spiral sampling reordering schemes (line in partition or partition in line) and different breath-hold positions (inspiration or expiration). Three experienced chest radiologists independently scored all the MR images for different pulmonary structures. Lung MR images from spiral acquisition protocol that received the highest image quality scores were also compared against corresponding CT images in 27 patients for evaluating diagnostic image quality and lesion identification. Spiral-VIBE-UTE MRI acquired with the line in partition reordering scheme in an inspiratory breath-holding position achieved the highest image quality scores (score range = 2.17-3.69) compared to others (score range = 1.7-3.29). Compared to corresponding chest CT images, three readers found that 81.5% (22 out of 27), 81.5% (22 out of 27) and 37% (10 out of 27) of the MR images were useful, respectively. Meanwhile, they all agreed that MRI could identify significant lesions in the lungs. The Spiral-VIBE-UTE sequence allows for fast imaging of the lung in a single breath hold. It could be a valuable tool for lung imaging without radiation and could provide great value for managing different lung diseases including assessment of post-COVID lesions.
Collapse
Affiliation(s)
- Valentin Fauveau
- BioMedical Engineering and Imaging Institute (BMEII), Icahn School of Medicine at Mount Sinai, New York, USA
| | - Adam Jacobi
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, USA
| | - Adam Bernheim
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, USA
| | - Michael Chung
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, USA
| | - Thomas Benkert
- MR Application Predevelopment, Siemens Healthcare GmbH, Erlangen, Germany
| | - Zahi A Fayad
- BioMedical Engineering and Imaging Institute (BMEII), Icahn School of Medicine at Mount Sinai, New York, USA; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, USA
| | - Li Feng
- BioMedical Engineering and Imaging Institute (BMEII), Icahn School of Medicine at Mount Sinai, New York, USA; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, USA.
| |
Collapse
|
10
|
Mei X, Liu Z, Robson PM, Marinelli B, Huang M, Doshi A, Jacobi A, Cao C, Link KE, Yang T, Wang Y, Greenspan H, Deyer T, Fayad ZA, Yang Y. RadImageNet: An Open Radiologic Deep Learning Research Dataset for Effective Transfer Learning. Radiology: Artificial Intelligence 2022; 4:e210315. [PMID: 36204533 PMCID: PMC9530758 DOI: 10.1148/ryai.210315] [Citation(s) in RCA: 40] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/17/2021] [Revised: 05/31/2022] [Accepted: 06/15/2022] [Indexed: 11/13/2022]
Abstract
Purpose To demonstrate the value of pretraining with millions of radiologic images compared with ImageNet photographic images on downstream medical applications when using transfer learning. Materials and Methods This retrospective study included patients who underwent a radiologic study between 2005 and 2020 at an outpatient imaging facility. Key images and associated labels from the studies were retrospectively extracted from the original study interpretation. These images were used for RadImageNet model training with random weight initiation. The RadImageNet models were compared with ImageNet models using the area under the receiver operating characteristic curve (AUC) for eight classification tasks and using Dice scores for two segmentation problems. Results The RadImageNet database consists of 1.35 million annotated medical images in 131 872 patients who underwent CT, MRI, and US for musculoskeletal, neurologic, oncologic, gastrointestinal, endocrine, abdominal, and pulmonary pathologic conditions. For transfer learning tasks on small datasets—thyroid nodules (US), breast masses (US), anterior cruciate ligament injuries (MRI), and meniscal tears (MRI)—the RadImageNet models demonstrated a significant advantage (P < .001) to ImageNet models (9.4%, 4.0%, 4.8%, and 4.5% AUC improvements, respectively). For larger datasets—pneumonia (chest radiography), COVID-19 (CT), SARS-CoV-2 (CT), and intracranial hemorrhage (CT)—the RadImageNet models also illustrated improved AUC (P < .001) by 1.9%, 6.1%, 1.7%, and 0.9%, respectively. Additionally, lesion localizations of the RadImageNet models were improved by 64.6% and 16.4% on thyroid and breast US datasets, respectively. Conclusion RadImageNet pretrained models demonstrated better interpretability compared with ImageNet models, especially for smaller radiologic datasets. Keywords: CT, MR Imaging, US, Head/Neck, Thorax, Brain/Brain Stem, Evidence-based Medicine, Computer Applications–General (Informatics) Supplemental material is available for this article. Published under a CC BY 4.0 license. See also the commentary by Cadrin-Chênevert in this issue.
Collapse
|
11
|
Arbiol AD, Patel S, Miller MA, Liao S, Robson P, Pyzik R, Jacobi A, Adams DH, El-Eshmawi A, Boateng P, Pandis D, Pugliese DN, Gandhi J, Ekanem E, Musikantow DR, Koruth JS, Wang W, Turagam M, Dukkipati SR, Reddy VY, Fayad Z, Patel S. PO-684-06 ARRHYTHMIC MITRAL VALVE PROLAPSE WITH ONLY MILD OR MODERATE MITRAL REGURGITATION: CHARACTERIZATION BY PET/MRI. Heart Rhythm 2022. [DOI: 10.1016/j.hrthm.2022.03.539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
12
|
Maier A, Liao SL, Lescure T, Robson PM, Hirata N, Sartori S, Narula N, Vergani V, Soultanidis G, Morgenthau A, Kovacic JC, Padilla M, Narula J, Jacobi A, Fayad ZA, Trivieri MG. Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis. JACC Cardiovasc Imaging 2021; 15:108-120. [PMID: 34274283 DOI: 10.1016/j.jcmg.2021.05.023] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/07/2020] [Revised: 05/25/2021] [Accepted: 05/26/2021] [Indexed: 02/05/2023]
Abstract
OBJECTIVES This study investigated whether pulmonary artery (PA) 18F-FDG uptake is associated with hypertension, and if it correlates to elevated pulmonary pressures. BACKGROUND 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with computed tomography or cardiac magnetic resonance (CMR) has been used to assess inflammation mostly in large arteries of the systemic circulation. Much less is known about inflammation of the vasculature of the pulmonary system and its relationship to pulmonary hypertension (PH). METHODS In a single-center cohort of 175 patients with suspected cardiac sarcoidosis, who underwent hybrid thoracic PET/CMR, 18F-FDG uptake in the PA was quantified according to maximum standardized uptake value (SUVmax) and target-to-background ratio (TBR) and compared with available results from right heart catheterization (RHC) or transthoracic echocardiography (TTE). RESULTS Thirty-three subjects demonstrated clear 18F-FDG uptake in the PA wall. In the subgroup of patients who underwent RHC (n = 10), the mean PA pressure was significantly higher in the group with PA 18F-FDG uptake compared with the group without uptake (34.4 ± 7.2 mm Hg vs 25.6 ± 9.3 mm Hg; P = 0.003), and 9 (90%) patients with PA 18F-FDG uptake had PH when a mean PA pressure cutoff of 25 mm Hg was used compared with 18 (45%) in the nonuptake group (P < 0.05). In the subgroup that underwent TTE, signs of PH were present in a significantly higher number of patients with PA 18F-FDG uptake (14 [51.9%] vs 37 [29.8%]; P < 0.05). Qualitative assessment of 18F-FDG uptake in the PA wall showed a sensitivity of 33% and specificity of 96% for separating patients with PH based on RHC-derived PA pressures. SUVmax and TBR in the PA wall correlated with PA pressure derived from RHC and/or TTE. CONCLUSIONS We demonstrate that 18F-FDG uptake by PET/CMR in the PA is associated with PH and that its intensity correlates with PA pressure.
Collapse
Affiliation(s)
- Alexander Maier
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - Steve Lin Liao
- Division of Noninvasive Cardiovascular Imaging at the Icahn School of Medicine at Mount Sinai, New York, USA
| | - Thomas Lescure
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Philip M Robson
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Naoki Hirata
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Samantha Sartori
- Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Navneet Narula
- Department of Pathology, New York University Langone Medical Center, New York, New York, USA
| | - Vittoria Vergani
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Georgios Soultanidis
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Adam Morgenthau
- Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Jason C Kovacic
- Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia; St Vincent's Clinical School, University of New South Wales, Darlinghurst, New South Wales, Australia
| | - Maria Padilla
- Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Jagat Narula
- Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Adam Jacobi
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Zahi A Fayad
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Maria G Trivieri
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
| |
Collapse
|
13
|
Kwon YJ(F, Toussie D, Finkelstein M, Cedillo MA, Maron SZ, Manna S, Voutsinas N, Eber C, Jacobi A, Bernheim A, Gupta YS, Chung MS, Fayad ZA, Glicksberg BS, Oermann EK, Costa AB. Combining Initial Radiographs and Clinical Variables Improves Deep Learning Prognostication in Patients with COVID-19 from the Emergency Department. Radiol Artif Intell 2021; 3:e200098. [PMID: 33928257 PMCID: PMC7754832 DOI: 10.1148/ryai.2020200098] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2020] [Revised: 11/20/2020] [Accepted: 12/02/2020] [Indexed: 12/15/2022]
Abstract
PURPOSE To train a deep learning classification algorithm to predict chest radiograph severity scores and clinical outcomes in patients with coronavirus disease 2019 (COVID-19). MATERIALS AND METHODS In this retrospective cohort study, patients aged 21-50 years who presented to the emergency department (ED) of a multicenter urban health system from March 10 to 26, 2020, with COVID-19 confirmation at real-time reverse-transcription polymerase chain reaction screening were identified. The initial chest radiographs, clinical variables, and outcomes, including admission, intubation, and survival, were collected within 30 days (n = 338; median age, 39 years; 210 men). Two fellowship-trained cardiothoracic radiologists examined chest radiographs for opacities and assigned a clinically validated severity score. A deep learning algorithm was trained to predict outcomes on a holdout test set composed of patients with confirmed COVID-19 who presented between March 27 and 29, 2020 (n = 161; median age, 60 years; 98 men) for both younger (age range, 21-50 years; n = 51) and older (age >50 years, n = 110) populations. Bootstrapping was used to compute CIs. RESULTS The model trained on the chest radiograph severity score produced the following areas under the receiver operating characteristic curves (AUCs): 0.80 (95% CI: 0.73, 0.88) for the chest radiograph severity score, 0.76 (95% CI: 0.68, 0.84) for admission, 0.66 (95% CI: 0.56, 0.75) for intubation, and 0.59 (95% CI: 0.49, 0.69) for death. The model trained on clinical variables produced an AUC of 0.64 (95% CI: 0.55, 0.73) for intubation and an AUC of 0.59 (95% CI: 0.50, 0.68) for death. Combining chest radiography and clinical variables increased the AUC of intubation and death to 0.88 (95% CI: 0.79, 0.96) and 0.82 (95% CI: 0.72, 0.91), respectively. CONCLUSION The combination of imaging and clinical information improves outcome predictions.Supplemental material is available for this article.© RSNA, 2020.
Collapse
Affiliation(s)
- Young Joon (Fred) Kwon
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Danielle Toussie
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Mark Finkelstein
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Mario A. Cedillo
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Samuel Z. Maron
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Sayan Manna
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Nicholas Voutsinas
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Corey Eber
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Adam Jacobi
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Adam Bernheim
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Yogesh Sean Gupta
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Michael S. Chung
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Zahi A. Fayad
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Benjamin S. Glicksberg
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Eric K. Oermann
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| | - Anthony B. Costa
- From the Department of Diagnostic, Molecular, and Interventional Radiology (Y.J.F.K., D.T., M.F., M.A.C., S.Z.M., S.M., N.V., C.E., A.J., A.B., Y.S.G., M.S.C., Z.A.F.), Department of Neurosurgery (Y.J.F.K., E.K.O., A.B.C.), Sinai BioDesign (Y.J.F.K., A.B.C.), BioMedical Engineering and Imaging Institute (Z.A.F.), Mount Sinai COVID Informatics Center (Z.A.F., B.S.G.), and The Hasso Plattner Institute for Digital Health at Mount Sinai (B.S.G.), Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1136, New York, NY 10029-6574
| |
Collapse
|
14
|
Gupta YS, Finkelstein M, Manna S, Toussie D, Bernheim A, Little BP, Concepcion J, Maron SZ, Jacobi A, Chung M, Kukar N, Voutsinas N, Cedillo MA, Fernandes A, Eber C, Fayad ZA, Hota P. Coronary artery calcification in COVID-19 patients: an imaging biomarker for adverse clinical outcomes. Clin Imaging 2021; 77:1-8. [PMID: 33601125 PMCID: PMC7875715 DOI: 10.1016/j.clinimag.2021.02.016] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2020] [Revised: 02/03/2021] [Accepted: 02/08/2021] [Indexed: 12/17/2022]
Abstract
BACKGROUND Recent studies have demonstrated a complex interplay between comorbid cardiovascular disease, COVID-19 pathophysiology, and poor clinical outcomes. Coronary artery calcification (CAC) may therefore aid in risk stratification of COVID-19 patients. METHODS Non-contrast chest CT studies on 180 COVID-19 patients ≥ age 21 admitted from March 1, 2020 to April 27, 2020 were retrospectively reviewed by two radiologists to determine CAC scores. Following feature selection, multivariable logistic regression was utilized to evaluate the relationship between CAC scores and patient outcomes. RESULTS The presence of any identified CAC was associated with intubation (AOR: 3.6, CI: 1.4-9.6) and mortality (AOR: 3.2, CI: 1.4-7.9). Severe CAC was independently associated with intubation (AOR: 4.0, CI: 1.3-13) and mortality (AOR: 5.1, CI: 1.9-15). A greater CAC score (UOR: 1.2, CI: 1.02-1.3) and number of vessels with calcium (UOR: 1.3, CI: 1.02-1.6) was associated with mortality. Visualized coronary stent or coronary artery bypass graft surgery (CABG) had no statistically significant association with intubation (AOR: 1.9, CI: 0.4-7.7) or death (AOR: 3.4, CI: 1.0-12). CONCLUSION COVID-19 patients with any CAC were more likely to require intubation and die than those without CAC. Increasing CAC and number of affected arteries was associated with mortality. Severe CAC was associated with higher intubation risk. Prior CABG or stenting had no association with elevated intubation or death.
Collapse
Affiliation(s)
- Yogesh Sean Gupta
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA.
| | - Mark Finkelstein
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Sayan Manna
- Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Danielle Toussie
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Adam Bernheim
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Brent P Little
- Department of Radiology, Massachusetts General Hospital, Boston, MA 02144, USA
| | - Jose Concepcion
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Samuel Z Maron
- Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Adam Jacobi
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Michael Chung
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Nina Kukar
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA; Department of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Nicholas Voutsinas
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Mario A Cedillo
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Ajit Fernandes
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Corey Eber
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Zahi A Fayad
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA; BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Partha Hota
- Division of Cardiothoracic Imaging, Atlantic Medical Imaging, Galloway, NJ 08205, USA
| |
Collapse
|
15
|
Pagano A, Finkelstein M, Overbey J, Steinberger S, Ellison T, Manna S, Toussie D, Cedillo MA, Jacobi A, Gupta YS, Bernheim A, Chung M, Eber C, Fayad ZA, Concepcion J. Portable Chest Radiography as an Exclusionary Test for Adverse Clinical Outcomes During the COVID-19 Pandemic. Chest 2021; 160:238-248. [PMID: 33516703 PMCID: PMC7844357 DOI: 10.1016/j.chest.2021.01.053] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2020] [Revised: 01/18/2021] [Accepted: 01/20/2021] [Indexed: 12/28/2022] Open
Abstract
Background Chest radiography (CXR) often is performed in the acute setting to help understand the extent of respiratory disease in patients with COVID-19, but a clearly defined role for negative chest radiograph results in assessing patients has not been described. Research Question Is portable CXR an effective exclusionary test for future adverse clinical outcomes in patients suspected of having COVID-19? Study Design and Methods Charts of consecutive patients suspected of having COVID-19 at five EDs in New York City between March 19, 2020, and April 23, 2020, were reviewed. Patients were categorized based on absence of findings on initial CXR. The primary outcomes were hospital admission, mechanical ventilation, ARDS, and mortality. Results Three thousand two hundred forty-five adult patients, 474 (14.6%) with negative initial CXR results, were reviewed. Among all patients, negative initial CXR results were associated with a low probability of future adverse clinical outcomes, with negative likelihood ratios of 0.27 (95% CI, 0.23-0.31) for hospital admission, 0.24 (95% CI, 0.16-0.37) for mechanical ventilation, 0.19 (95% CI, 0.09-0.40) for ARDS, and 0.38 (95% CI, 0.29-0.51) for mortality. Among the subset of 955 patients younger than 65 years and with a duration of symptoms of at least 5 days, no patients with negative CXR results died, and the negative likelihood ratios were 0.17 (95% CI, 0.12-0.25) for hospital admission, 0.09 (95% CI, 0.02-0.36) for mechanical ventilation, and 0.09 (95% CI, 0.01-0.64) for ARDS. Interpretation Initial CXR in adult patients suspected of having COVID-19 is a strong exclusionary test for hospital admission, mechanical ventilation, ARDS, and mortality. The value of CXR as an exclusionary test for adverse clinical outcomes is highest among young adults, patients with few comorbidities, and those with a prolonged duration of symptoms.
Collapse
Affiliation(s)
- Andrew Pagano
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
| | - Mark Finkelstein
- Department of Diagnostic, Molecular, and Interventional Radiology, Mount Sinai Hospital, New York, NY
| | - Jessica Overbey
- Department of Population Health Science and Policy, Mount Sinai Hospital, New York, NY
| | | | - Trevor Ellison
- Department of Diagnostic, Molecular, and Interventional Radiology, Mount Sinai Hospital, New York, NY
| | - Sayan Manna
- Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY
| | - Danielle Toussie
- Department of Diagnostic, Molecular, and Interventional Radiology, Mount Sinai Hospital, New York, NY
| | - Mario A Cedillo
- Department of Diagnostic, Molecular, and Interventional Radiology, Mount Sinai Hospital, New York, NY
| | - Adam Jacobi
- Department of Diagnostic, Molecular, and Interventional Radiology, Mount Sinai Hospital, New York, NY
| | - Yogesh S Gupta
- Department of Diagnostic, Molecular, and Interventional Radiology, Mount Sinai Hospital, New York, NY
| | - Adam Bernheim
- Department of Diagnostic, Molecular, and Interventional Radiology, Mount Sinai Hospital, New York, NY
| | - Michael Chung
- Department of Diagnostic, Molecular, and Interventional Radiology, Mount Sinai Hospital, New York, NY
| | - Corey Eber
- Department of Diagnostic, Molecular, and Interventional Radiology, Mount Sinai Hospital, New York, NY
| | - Zahi A Fayad
- Department of Diagnostic, Molecular, and Interventional Radiology, Mount Sinai Hospital, New York, NY; BioMedical Engineering and Imaging Institute, Mount Sinai Hospital, New York, NY
| | - Jose Concepcion
- Department of Diagnostic, Molecular, and Interventional Radiology, Mount Sinai Hospital, New York, NY
| |
Collapse
|
16
|
Housman B, Jacobi A, Carollo A, Nobel T, Eber C, Acquah S, Powell C, Kaufman A, Lee DS, Nicastri D, Hakami A, Song K, Kohli-Seth R, Flores R. COVID-19 ventilator barotrauma management: less is more. Ann Transl Med 2020; 8:1575. [PMID: 33437774 PMCID: PMC7791221 DOI: 10.21037/atm-20-3907] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Background COVID-19 patients requiring mechanical ventilation may develop significant pneumomediastinum and sub-cutaneous emphysema without associated pneumothorax (SWAP). Prophylactic chest tube placement or sub-fascial "blowholes" are usually recommended to prevent tension pneumothorax and clinical decline. Risk of iatrogenic lung injury and release of virus into the environment is high. Incidence and conservative management data of such barotraumatic complications during the COVID-19 pandemic are lacking. Methods All patients with mediastinal air and SWAP evaluated by the department of Thoracic Surgery at the Mount Sinai Hospital between March 30 and April 10, 2020 were identified. All patients without pneumothorax were treated conservatively with daily chest x-ray and observation. Three patients had prophylactic chest tube placement prior to the study period without thoracic surgery consultation. Results There were 29 cases of mediastinal air with SWAP out of 171 COVID positive intubated patients (17.0%) who were treated conservatively. Patients were intubated for an average of 2.4 days before SWAP was identified. 12 patients (41%) had improvement or resolution without intervention. Two patients progressed to pneumothorax 3 and 8 days following initial presentation. Both had chest tubes placed without incident before there were any changes in oxygenation, hemodynamics, supportive medications, or ventilator settings. There were 3 patients who had percutaneous tubes placed before the study period all of whom had significant worsening of their sub-cutaneous air and air leak. Conclusions Conservative management of massive sub-cutaneous emphysema without pneumothorax in COVID-19 patients is safe and limits viral exposure to healthcare workers. Placement of chest tubes is discouraged unless a definite sizable pneumothorax develops.
Collapse
Affiliation(s)
- Brian Housman
- Thoracic Surgery Department, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Adam Jacobi
- Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Andrea Carollo
- Thoracic Surgery Department, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Tamar Nobel
- Thoracic Surgery Department, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Corey Eber
- Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Samuel Acquah
- Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Charles Powell
- Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Andrew Kaufman
- Thoracic Surgery Department, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Dong-Seok Lee
- Thoracic Surgery Department, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Daniel Nicastri
- Thoracic Surgery Department, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Ardeshir Hakami
- Thoracic Surgery Department, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Kimberly Song
- Thoracic Surgery Department, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Roopa Kohli-Seth
- Surgery, Institute for Critical Care Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| | - Raja Flores
- Thoracic Surgery Department, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
| |
Collapse
|
17
|
Manna S, Maron SZ, Cedillo MA, Voutsinas N, Toussie D, Finkelstein M, Steinberger S, Chung M, Bernheim A, Eber C, Gupta YS, Concepcion J, Libes R, Jacobi A. Spontaneous subcutaneous emphysema and pneumomediastinum in non-intubated patients with COVID-19. Clin Imaging 2020; 67:207-213. [PMID: 32871424 PMCID: PMC7448957 DOI: 10.1016/j.clinimag.2020.08.013] [Citation(s) in RCA: 40] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2020] [Revised: 07/28/2020] [Accepted: 08/18/2020] [Indexed: 02/08/2023]
Abstract
PURPOSE We describe the presenting characteristics and hospital course of 11 novel coronavirus (COVID-19) patients who developed spontaneous subcutaneous emphysema (SE) with or without pneumomediastinum (SPM) in the absence of prior mechanical ventilation. MATERIALS AND METHODS A total of 11 non-intubated COVID-19 patients (8 male and 3 female, median age 61 years) developed SE and SPM between March 15 and April 30, 2020 at a multi-center urban health system in New York City. Demographics (age, gender, smoking status, comorbid conditions, and body-mass index), clinical variables (temperature, oxygen saturation, and symptoms), and laboratory values (white blood cell count, C-reactive protein, D-dimer, and peak interleukin-6) were collected. Chest radiography (CXR) and computed tomography (CT) were analyzed for SE, SPM, and pneumothorax by a board-certified cardiothoracic-fellowship trained radiologist. RESULTS Eleven non-intubated patients developed SE, 36% (4/11) of whom had SE on their initial CXR. Concomitant SPM was apparent in 91% (10/11) of patients, and 45% (5/11) also developed pneumothorax. Patients developed SE on average 13.3 days (SD: 6.3) following symptom onset. No patients reported a history of smoking. The most common comorbidities included hypertension (6/11), diabetes mellitus (5/11), asthma (3/11), dyslipidemia (3/11), and renal disease (2/11). Four (36%) patients expired during hospitalization. CONCLUSION SE and SPM were observed in a cohort of 11 non-intubated COVID-19 patients without any known cause or history of invasive ventilation. Further investigation is required to elucidate the underlying mechanism in this patient population.
Collapse
Affiliation(s)
- Sayan Manna
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA.
| | - Samuel Z Maron
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Mario A Cedillo
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Nicholas Voutsinas
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Danielle Toussie
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Mark Finkelstein
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Sharon Steinberger
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Michael Chung
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Adam Bernheim
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Corey Eber
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Yogesh Sean Gupta
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Jose Concepcion
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Richard Libes
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| | - Adam Jacobi
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA
| |
Collapse
|
18
|
Voutsinas N, Sun J, Chung M, Jacobi A, Genes N, Nassisi D, Halton K, Delman B. Improving Communication Between the Emergency Department and Radiology Department With a Novel Web-Based Tool in an Urban Academic Center. Curr Probl Diagn Radiol 2020; 50:293-296. [PMID: 33082082 DOI: 10.1067/j.cpradiol.2020.09.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2020] [Revised: 08/26/2020] [Accepted: 09/15/2020] [Indexed: 11/22/2022]
Abstract
DESCRIPTION OF PROBLEM Streamlining communication between radiology and referring services is vital to ensure appropriate care with minimal delays. Increased subspecialization has led to compartmentalization of the radiology department with many physicians working in disparate areas. At our hospital, we anecdotally noted that a significant portion of incoming phone calls were misdirected to the wrong workstations. This resulted in wasted time, unnecessary interruptions, and delays in care because the referring clinicians could not efficiently navigate the radiology department staffing structure. Our quality improvement project involved developing a web-based tool allowing the emergency department (ED) to more efficiently contact the appropriate radiology desk and reduce misdirected phone calls. INSTITUTIONAL APPROACH EMPLOYED TO ADDRESS THE PROBLEM Surveys were sent to radiology residents and ED providers (attendings, residents, physician assistants) to assess how often phone calls were misdirected to the wrong radiology station. Radiology residents were asked which stations received the most misdirected phone calls, and what station the caller was often looking for. ED providers were asked which stations they intended when they were told they called the wrong station, and a series of questions in the survey assessed their knowledge of commonly called radiology station (Plain Film, CT Body, Ultrasound, Neuoradiology, Pediatrics, and Overnight Desk). ED and radiology physicians worked together to design a simple, easily accessed web-based tool that allowed the ED clinicians to determine which station should be called during for each hour of the day, which integrated differences in staffing by radiology throughout the day. After the tool had been implemented for 8 months, surveys were again sent to radiology residents and ED clinicians asking the same questions as before to assess for any significant change in response. Additional questions were added to the ED survey to assess awareness of the new tool. DESCRIPTION OF OUTCOMES IN CHANGE OF PRACTICE An interactive, easily updated schedule with optimal contact numbers was made available through the ED intranet. The design allowed for easy modification of contact numbers over time to accommodate changes in coverage location or staffing models. Prior to implementation contact information was presented on a static screen, which was unable to be changed and included multiple incorrect and defunct numbers. Additionally, contact defaulted to a general radiology pager, which was carried by a resident only responsible for plain films for most of the day. Numbers included in the new intranet tool were all pertinent reading room stations, all scheduling desks, and all technologist workspaces. Different schedules were provided for weekdays and weekends. Initial survey results showed that prior to the intervention, 74% of radiology residents said they received misdirected phone calls at least twice a day, and 57.9% of ED respondents reached the wrong recipient at least once per day. Frequencies of misdirected calls dropped to 58.4% of radiology residents (P = 0.37) and 17.9% of ED respondents (P < 0.01) on follow-up surveys 8 months after the tool was established. After establishing the new tool, 82.1% of ED respondents were aware of the new intranet contact tool and were using it to contact radiology. On the series of questions assessing ED respondents' knowledge of radiology numbers, over 50% of respondents knew the correct answer or answered using the call sheet after implementation; this resulted in statistically significant increases in accuracy for Body, Neuroradiology, and Pediatric radiology stations. Furthermore, with the exception of ED plain films, there was a statistically significant reduction in number of responses who said the general radiology pager should be called for reads. Fifty percent of radiology residents believed there was a reduction in the number of misdirected phone calls from the ED with this tool. CONCLUSION, LIMITATIONS, AND DESCRIPTIONS OF FUTURE DIRECTIONS Our tool was successful in accomplishing multiple goals. First, over 80% of ED respondents adopted the new tool. Second, the number of misdirected phone calls based on the subjective perception of ED respondents and radiology residents was reduced. Third, we objectively improved the ED respondents' behavior pattern in contacting the radiology department by either calling the correct number using the call tool, and by reducing the number of respondents who use the pager. Going forward, we hope to be able to expand use of this tool throughout the hospital in order to provide more timely and efficient care with other services by streamlining access between referring services and the appropriate radiology recipients.
Collapse
Affiliation(s)
- Nicholas Voutsinas
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY.
| | - Jean Sun
- Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, NY
| | - Michael Chung
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY
| | - Adam Jacobi
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY
| | - Nicholas Genes
- Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, NY
| | - Denise Nassisi
- Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, NY
| | - Kathleen Halton
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY
| | - Bradley Delman
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY
| |
Collapse
|
19
|
Jaeschke A, Jacobi A, Lawrence M, Risbridger G, Frydenberg M, Williams E, Vela I, Hutmacher D, Bray L, Taubenberger A. Cancer-associated fibroblasts of the prostate promote a compliant and more invasive phenotype in benign prostate epithelial cells. Mater Today Bio 2020; 8:100073. [PMID: 32984808 PMCID: PMC7498830 DOI: 10.1016/j.mtbio.2020.100073] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2020] [Revised: 07/30/2020] [Accepted: 08/07/2020] [Indexed: 01/04/2023] Open
Abstract
Reciprocal interactions between prostate epithelial cells and their adjacent stromal microenvironment not only are essential for tissue homeostasis but also play a key role in tumor development and progression. Malignant transformation is associated with the formation of a reactive stroma where cancer-associated fibroblasts (CAFs) induce matrix remodeling and thereby provide atypical biochemical and biomechanical signals to epithelial cells. Previous work has been focused on the cellular and molecular phenotype as well as on matrix stiffness and remodeling, providing potential targets for cancer therapeutics. So far, biomechanical changes in CAFs and adjacent epithelial cells of the prostate have not been explored. Here, we compared the mechanical properties of primary prostatic CAFs and patient-matched non-malignant prostate tissue fibroblasts (NPFs) using atomic force microscopy (AFM) and real-time deformability cytometry (RT-FDC). It was found that CAFs exhibit an increased apparent Young's modulus, coinciding with an altered architecture of the cytoskeleton compared with NPFs. In contrast, co-cultures of benign prostate epithelial (BPH-1) cells with CAFs resulted in a decreased stiffness of the epithelial cells, as well as an elongated morphological phenotype, when compared with co-cultures with NPFs. Moreover, the presence of CAFs increased proliferation and invasion of epithelial cells, features typically associated with tumor progression. Altogether, this study provides novel insights into the mechanical interactions between epithelial cells with the malignant prostate microenvironment, which could potentially be explored for new diagnostic approaches.
Collapse
Affiliation(s)
- A. Jaeschke
- Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Australia
- School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology (QUT), Brisbane, Australia
| | - A. Jacobi
- Biotechnology Center, Technische Universität Dresden, Germany
- Max Planck Institute for the Science of Light & Max-Planck-Zentrum für Physik und Medizin, Erlangen, Germany
| | - M.G. Lawrence
- Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
- Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia
| | - G.P. Risbridger
- Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
- Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia
| | - M. Frydenberg
- Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
- Australian Urology Associates, Melbourne, Victoria, Australia
- Department of Urology, Cabrini Health, Malvern, Victoria, Australia
| | - E.D. Williams
- Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Australia
- Australian Prostate Cancer Research Centre-Queensland, Queensland University of Technology (QUT), Kelvin Grove, Australia
- Translational Research Institute, Woolloongabba, Australia
- School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Brisbane, Australia
| | - I. Vela
- Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Australia
- Australian Prostate Cancer Research Centre-Queensland, Queensland University of Technology (QUT), Kelvin Grove, Australia
- Translational Research Institute, Woolloongabba, Australia
- School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Brisbane, Australia
- Department of Urology, Princess Alexandra Hospital, Woolloongabba, Australia
| | - D.W. Hutmacher
- Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Australia
- School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology (QUT), Brisbane, Australia
- School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Brisbane, Australia
| | - L.J. Bray
- Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Australia
- School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology (QUT), Brisbane, Australia
| | - A. Taubenberger
- Biotechnology Center, Technische Universität Dresden, Germany
| |
Collapse
|
20
|
Barazani SH, Chi WW, Pyzik R, Chang H, Jacobi A, O’Donnell T, Fayad ZA, Ali Y, Mani V. Quantification of uric acid in vasculature of patients with gout using dual-energy computed tomography. World J Radiol 2020; 12:184-194. [PMID: 32913564 PMCID: PMC7457162 DOI: 10.4329/wjr.v12.i8.184] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/09/2020] [Revised: 06/16/2020] [Accepted: 07/19/2020] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Gout, caused by hyperuricemia and subsequent deposition of aggregated monosodium urate crystals (MSU) in the joints or extra-articular regions, is the most common inflammatory arthritis. There is increasing evidence that gout is an independent risk factor for hypertension, cardiovascular disease progression and mortality.
AIM To evaluate if dual energy computed tomography (DECT) could identify MSU within vessel walls of gout patients, and if MSU deposits within the vasculature differed between patients with gout and controls. This study may help elucidate why individuals with gout have increased risk for cardiovascular disease.
METHODS 31 gout patients and 18 controls underwent DECT scans of the chest and abdomen. A material decomposition algorithm was used to distinguish regions of MSU (coded green), and calcifications (coded purple) from soft tissue (uncoded). Volume of green regions was calculated using a semi-automated volume assessment program. Between-group differences were analyzed using Mann-Whitney U exact test and nonparametric rank regression.
RESULTS Gout patients had significantly higher volume of MSU within the aorta compared to controls [Median (Min-Max) of 43.9 (0-1113.5) vs 2.9 (0-219.4), P = 0.01]. Number of deposits was higher in gout patients compared to controls [Median (Min-Max) of 20 (0-739) vs 1.5 (0-104), P = 0.008]. However, the difference was insignificant after adjustment for age, gender, history of cardiovascular disease and diabetes. Increased age was positively associated with total urate volume (rs = 0.64; 95% confidence interval: 0.43-0.78).
CONCLUSION This pilot study showed that DECT can quantify vascular urate deposits with variation across groups, with gout patients possibly having higher deposition. This relationship disappeared when adjusted for age, and there was a positive relationship between age and MSU deposition. While this study does not prove that green coded regions are truly MSU deposition, it corroborates recent studies that show the presence of vascular deposition.
Collapse
Affiliation(s)
- Sharon Hannah Barazani
- Department of Radiology, Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
| | - Wei-Wei Chi
- Division of Rheumatology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
| | - Renata Pyzik
- Department of Radiology, Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
| | - Helena Chang
- Center for Biostatistics, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
| | - Adam Jacobi
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
| | | | - Zahi A Fayad
- Department of Radiology, Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
| | - Yousaf Ali
- Division of Rheumatology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
| | - Venkatesh Mani
- Department of Radiology, Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
| |
Collapse
|
21
|
Abstract
As the global pandemic of coronavirus disease-19 (COVID-19) progresses, many physicians in a wide variety of specialties continue to play pivotal roles in diagnosis and management. In radiology, much of the literature to date has focused on chest CT manifestations of COVID-19 (Zhou et al. [1]; Chung et al. [2]). However, due to infection control issues related to patient transport to CT suites, the inefficiencies introduced in CT room decontamination, and lack of CT availability in parts of the world, portable chest radiography (CXR) will likely be the most commonly utilized modality for identification and follow up of lung abnormalities. In fact, the American College of Radiology (ACR) notes that CT decontamination required after scanning COVID-19 patients may disrupt radiological service availability and suggests that portable chest radiography may be considered to minimize the risk of cross-infection (American College of Radiology [3]). Furthermore, in cases of high clinical suspicion for COVID-19, a positive CXR may obviate the need for CT. Additionally, CXR utilization for early disease detection may also play a vital role in areas around the world with limited access to reliable real-time reverse transcription polymerase chain reaction (RT-PCR) COVID testing. The purpose of this pictorial review article is to describe the most common manifestations and patterns of lung abnormality on CXR in COVID-19 in order to equip the medical community in its efforts to combat this pandemic.
Collapse
Affiliation(s)
- Adam Jacobi
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY. 1 Gustave L. Levy Pl, Bix 1234, New York, NY 10029, United States of America.
| | - Michael Chung
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY. 1 Gustave L. Levy Pl, Bix 1234, New York, NY 10029, United States of America.
| | - Adam Bernheim
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY. 1 Gustave L. Levy Pl, Bix 1234, New York, NY 10029, United States of America.
| | - Corey Eber
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY. 1 Gustave L. Levy Pl, Bix 1234, New York, NY 10029, United States of America.
| |
Collapse
|
22
|
Mei X, Lee HC, Diao KY, Huang M, Lin B, Liu C, Xie Z, Ma Y, Robson PM, Chung M, Bernheim A, Mani V, Calcagno C, Li K, Li S, Shan H, Lv J, Zhao T, Xia J, Long Q, Steinberger S, Jacobi A, Deyer T, Luksza M, Liu F, Little BP, Fayad ZA, Yang Y. Artificial intelligence-enabled rapid diagnosis of patients with COVID-19. Nat Med 2020; 26:1224-1228. [PMID: 32427924 PMCID: PMC7446729 DOI: 10.1038/s41591-020-0931-3] [Citation(s) in RCA: 495] [Impact Index Per Article: 123.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2020] [Accepted: 05/07/2020] [Indexed: 02/05/2023]
Abstract
For diagnosis of coronavirus disease 2019 (COVID-19), a SARS-CoV-2 virus-specific reverse transcriptase polymerase chain reaction (RT-PCR) test is routinely used. However, this test can take up to 2 d to complete, serial testing may be required to rule out the possibility of false negative results and there is currently a shortage of RT-PCR test kits, underscoring the urgent need for alternative methods for rapid and accurate diagnosis of patients with COVID-19. Chest computed tomography (CT) is a valuable component in the evaluation of patients with suspected SARS-CoV-2 infection. Nevertheless, CT alone may have limited negative predictive value for ruling out SARS-CoV-2 infection, as some patients may have normal radiological findings at early stages of the disease. In this study, we used artificial intelligence (AI) algorithms to integrate chest CT findings with clinical symptoms, exposure history and laboratory testing to rapidly diagnose patients who are positive for COVID-19. Among a total of 905 patients tested by real-time RT-PCR assay and next-generation sequencing RT-PCR, 419 (46.3%) tested positive for SARS-CoV-2. In a test set of 279 patients, the AI system achieved an area under the curve of 0.92 and had equal sensitivity as compared to a senior thoracic radiologist. The AI system also improved the detection of patients who were positive for COVID-19 via RT-PCR who presented with normal CT scans, correctly identifying 17 of 25 (68%) patients, whereas radiologists classified all of these patients as COVID-19 negative. When CT scans and associated clinical history are available, the proposed AI system can help to rapidly diagnose COVID-19 patients.
Collapse
Affiliation(s)
- Xueyan Mei
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Hao-Chih Lee
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Kai-Yue Diao
- Department of Radiology, West China Hospital, Sichuan University, Chengdu, China
| | - Mingqian Huang
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Bin Lin
- Department of Radiology, The Second Affiliated Hospital of Zhejiang University, Hangzhou, China
| | - Chenyu Liu
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Zongyu Xie
- Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
| | - Yixuan Ma
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Philip M Robson
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Michael Chung
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Adam Bernheim
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Venkatesh Mani
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Claudia Calcagno
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Kunwei Li
- Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital of Sun Yet-sen University, Zhuhai, China
| | - Shaolin Li
- Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital of Sun Yet-sen University, Zhuhai, China
| | - Hong Shan
- Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital of Sun Yet-sen University, Zhuhai, China
| | - Jian Lv
- Department of Radiology, Nanxishan Hospital, Guilin, China
| | - Tongtong Zhao
- Department of Radiology, The Second People's Hospital, Fuyang, China
| | - Junli Xia
- Department of Radiology, Bozhou Bone Trauma Hospital Image Center, Bozhou, China
| | - Qihua Long
- Department of Radiology, Remin Hospital of Wuhan University, Wuhan, China
| | - Sharon Steinberger
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Adam Jacobi
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Timothy Deyer
- East River Medical Imaging, New York, NY, USA
- Department of Radiology, Weill Cornell Medicine, New York, NY, USA
| | - Marta Luksza
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Fang Liu
- Department of Radiology, Massachusetts General Hospital, Boston, MA, USA
| | - Brent P Little
- Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.
| | - Zahi A Fayad
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
| | - Yang Yang
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
| |
Collapse
|
23
|
King MJ, Lewis S, El Homsi M, Hernandez Meza G, Bernheim A, Jacobi A, Chung M, Taouli B. Lung base CT findings in COVID-19 adult patients presenting with acute abdominal complaints: case series from a major New York City health system. Eur Radiol 2020; 30:6685-6693. [PMID: 32623503 PMCID: PMC7334123 DOI: 10.1007/s00330-020-07040-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Revised: 06/06/2020] [Accepted: 06/17/2020] [Indexed: 01/08/2023]
Abstract
Objective To describe demographic, clinical, and lung base CT findings in COVID-19 patients presenting with abdominal complaints. Methods In this retrospective study, 76 COVID-19 patients who underwent abdominal CT for abdominal complaints from March 1 to April 15, 2020, in a large urban multihospital Health System were included. Those with positive abdominal CT findings (n = 14) were then excluded, with 62 patients undergoing final analysis (30M/32F; median age 63 years, interquartile range (IQR) 52–75 years, range 30–90 years). Demographic and clinical data were extracted. CT lung base assessment was performed by a cardiothoracic radiologist. Data were compared between discharged and hospitalised patients using Wilcoxon or Fisher’s exact tests. Results The majority of the population was non-elderly (56.4%, < 65 years) and most (81%) had underlying health conditions. Nineteen percent were discharged and 81% were hospitalised. The most frequent abdominal symptoms were pain (83.9%) and nausea/vomiting/anorexia (46.8%). Lung base CT findings included ground-glass opacities (95.2%) in a multifocal (95.2%) and peripheral (66.1%) distribution. Elevated laboratory values (when available) included C-reactive protein (CRP) (97.3%), D-dimer (79.4%), and ferritin (68.8% of males and 81.8% of females). Older age (p = 0.045), hypertension (p = 0.019), and lower haemoglobin in women (p = 0.042) were more frequent in hospitalised patients. There was no difference in lung base CT findings between discharged and hospitalised patients (p > 0.165). Conclusions COVID-19 patients can present with abdominal symptoms, especially in non-elderly patients with underlying health conditions. Lung base findings on abdominal CT are consistent with published reports. Radiologists should be aware of atypical presentations of COVID-19. Key Points • COVID-19 infected patients can present with acute abdominal symptoms, especially in non-elderly patients with underlying health conditions, and may frequently require hospitalisation (81%). • There was no difference in lung base CT findings between patients who were discharged and those who were hospitalised. • Lung base CT findings included multifocal and peripheral ground-glass opacities, consistent with published reports.
Collapse
Affiliation(s)
- Michael J King
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY, 10029-6574, USA
| | - Sara Lewis
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY, 10029-6574, USA. .,BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY, 10029-6574, USA.
| | - Maria El Homsi
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY, 10029-6574, USA
| | - Gabriela Hernandez Meza
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY, 10029-6574, USA
| | - Adam Bernheim
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY, 10029-6574, USA
| | - Adam Jacobi
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY, 10029-6574, USA
| | - Michael Chung
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY, 10029-6574, USA
| | - Bachir Taouli
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY, 10029-6574, USA.,BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY, 10029-6574, USA
| |
Collapse
|
24
|
El Homsi M, Chung M, Bernheim A, Jacobi A, King MJ, Lewis S, Taouli B. Review of chest CT manifestations of COVID-19 infection. Eur J Radiol Open 2020; 7:100239. [PMID: 32550256 PMCID: PMC7276000 DOI: 10.1016/j.ejro.2020.100239] [Citation(s) in RCA: 38] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Revised: 06/03/2020] [Accepted: 06/04/2020] [Indexed: 02/07/2023] Open
Abstract
Coronavirus disease-19 (COVID-19) is a viral pandemic that started in China and has rapidly expanded worldwide. Typical clinical manifestations include fever, cough and dyspnea after an incubation period of 2-14 days. The diagnosis is based on RT-PCR test through a nasopharyngeal swab. Because of the pulmonary tropism of the virus, pneumonia is often encountered in symptomatic patients. Here, we review the pertinent clinical findings and the current published data describing chest CT findings in COVID-19 pneumonia, the diagnostic performance of CT for diagnosis, including differential diagnosis, as well the evolving role of imaging in this disease.
Collapse
Key Words
- ARDS, acute respiratory distress syndrome
- CAP, community-acquired pneumonia
- COVID-19
- COVID-19, coronavirus disease 2019
- CRP, C-Reactive Protein
- CT chest
- Coronavirus
- GGO, ground-glass opacity
- MERS, Middle East respiratory syndrome
- PUI, patient under investigation
- RT-PCR
- RT-PCR, reverse transcription polymerase chain reaction
- SARS, severe acute respiratory syndrome
- SARSCoV-2, severe acute respiratory syndrome coronavirus 2
Collapse
Affiliation(s)
- Maria El Homsi
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA
| | - Michael Chung
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA
| | - Adam Bernheim
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA
| | - Adam Jacobi
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA
| | - Michael J. King
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA
| | - Sara Lewis
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, USA
| | - Bachir Taouli
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, USA
| |
Collapse
|
25
|
Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, Diao K, Lin B, Zhu X, Li K, Li S, Shan H, Jacobi A, Chung M. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology 2020; 295:200463. [PMID: 32077789 PMCID: PMC7233369 DOI: 10.1148/radiol.2020200463] [Citation(s) in RCA: 1540] [Impact Index Per Article: 385.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
In this retrospective study, chest CTs of 121 symptomatic patients infected with coronavirus disease-19 (COVID-19) from four centers in China from January 18, 2020 to February 2, 2020 were reviewed for common CT findings in relationship to the time between symptom onset and the initial CT scan (i.e. early, 0-2 days (36 patients), intermediate 3-5 days (33 patients), late 6-12 days (25 patients)). The hallmarks of COVID-19 infection on imaging were bilateral and peripheral ground-glass and consolidative pulmonary opacities. Notably, 20/36 (56%) of early patients had a normal CT. With a longer time after the onset of symptoms, CT findings were more frequent, including consolidation, bilateral and peripheral disease, greater total lung involvement, linear opacities, "crazy-paving" pattern and the "reverse halo" sign. Bilateral lung involvement was observed in 10/36 early patients (28%), 25/33 intermediate patients (76%), and 22/25 late patients (88%).
Collapse
Affiliation(s)
- Adam Bernheim
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Xueyan Mei
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Mingqian Huang
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Yang Yang
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Zahi A. Fayad
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Ning Zhang
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Kaiyue Diao
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Bin Lin
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Xiqi Zhu
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Kunwei Li
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Shaolin Li
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Hong Shan
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Adam Jacobi
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| | - Michael Chung
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B., M.H., Y.Y., A.J., M.C); BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (X.M); Department of Diagnostic, Molecular and Interventional Radiology, and BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York (Z.A.F); Department of Radiology, The First Affiliated Hospital of Nanchang University, NanChang, JiangXi, China (N.Z); Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan, China (K.D); Department of Radiology, The Second Affiliated Hospital of Zhejiang University School Medicine, Hangzhou, China (B.L); Department of Radiology, Nanxishan Hospital, Guangxi Zhuang Autonomous Region, China (X.Z); Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, New Xiangzhou, Zhuhai, Guangdong Province, China (K.L., S.L., H.S)
| |
Collapse
|
26
|
Manna S, Wruble J, Maron SZ, Toussie D, Voutsinas N, Finkelstein M, Cedillo MA, Diamond J, Eber C, Jacobi A, Chung M, Bernheim A. COVID-19: A Multimodality Review of Radiologic Techniques, Clinical Utility, and Imaging Features. Radiol Cardiothorac Imaging 2020; 2:e200210. [PMID: 33778588 PMCID: PMC7325394 DOI: 10.1148/ryct.2020200210] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2020] [Revised: 05/14/2020] [Accepted: 05/27/2020] [Indexed: 12/18/2022]
Abstract
In this article we will review the imaging features of coronavirus disease 2019 (COVID-19) across multiple modalities, including radiography, CT, MRI, PET/CT, and US. Given that COVID-19 primarily affects the lung parenchyma by causing pneumonia, our directive is to focus on thoracic findings associated with COVID-19. We aim to enhance radiologists' understanding of this disease to help guide diagnosis and management. Supplemental material is available for this article. © RSNA, 2020.
Collapse
Affiliation(s)
| | | | - Samuel Z. Maron
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY 10029 (S.M., S.Z.M., D.T., N.V., M.F., M.A.C., C.E., A.J., M.C., A.B.); Complete Radiology Reading Services, Westbury, NY (J.W.); Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (J.W.); Department of Radiology, University of Connecticut, Farmington, Conn (J.W.); Department of Radiology and Biomedical Imaging, The Johns Hopkins Hospital, Baltimore, Md (J.W.); and Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass (J.D.)
| | - Danielle Toussie
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY 10029 (S.M., S.Z.M., D.T., N.V., M.F., M.A.C., C.E., A.J., M.C., A.B.); Complete Radiology Reading Services, Westbury, NY (J.W.); Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (J.W.); Department of Radiology, University of Connecticut, Farmington, Conn (J.W.); Department of Radiology and Biomedical Imaging, The Johns Hopkins Hospital, Baltimore, Md (J.W.); and Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass (J.D.)
| | - Nicholas Voutsinas
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY 10029 (S.M., S.Z.M., D.T., N.V., M.F., M.A.C., C.E., A.J., M.C., A.B.); Complete Radiology Reading Services, Westbury, NY (J.W.); Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (J.W.); Department of Radiology, University of Connecticut, Farmington, Conn (J.W.); Department of Radiology and Biomedical Imaging, The Johns Hopkins Hospital, Baltimore, Md (J.W.); and Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass (J.D.)
| | - Mark Finkelstein
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY 10029 (S.M., S.Z.M., D.T., N.V., M.F., M.A.C., C.E., A.J., M.C., A.B.); Complete Radiology Reading Services, Westbury, NY (J.W.); Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (J.W.); Department of Radiology, University of Connecticut, Farmington, Conn (J.W.); Department of Radiology and Biomedical Imaging, The Johns Hopkins Hospital, Baltimore, Md (J.W.); and Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass (J.D.)
| | - Mario A. Cedillo
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY 10029 (S.M., S.Z.M., D.T., N.V., M.F., M.A.C., C.E., A.J., M.C., A.B.); Complete Radiology Reading Services, Westbury, NY (J.W.); Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (J.W.); Department of Radiology, University of Connecticut, Farmington, Conn (J.W.); Department of Radiology and Biomedical Imaging, The Johns Hopkins Hospital, Baltimore, Md (J.W.); and Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass (J.D.)
| | - Jamie Diamond
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY 10029 (S.M., S.Z.M., D.T., N.V., M.F., M.A.C., C.E., A.J., M.C., A.B.); Complete Radiology Reading Services, Westbury, NY (J.W.); Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (J.W.); Department of Radiology, University of Connecticut, Farmington, Conn (J.W.); Department of Radiology and Biomedical Imaging, The Johns Hopkins Hospital, Baltimore, Md (J.W.); and Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass (J.D.)
| | - Corey Eber
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY 10029 (S.M., S.Z.M., D.T., N.V., M.F., M.A.C., C.E., A.J., M.C., A.B.); Complete Radiology Reading Services, Westbury, NY (J.W.); Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (J.W.); Department of Radiology, University of Connecticut, Farmington, Conn (J.W.); Department of Radiology and Biomedical Imaging, The Johns Hopkins Hospital, Baltimore, Md (J.W.); and Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass (J.D.)
| | - Adam Jacobi
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY 10029 (S.M., S.Z.M., D.T., N.V., M.F., M.A.C., C.E., A.J., M.C., A.B.); Complete Radiology Reading Services, Westbury, NY (J.W.); Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (J.W.); Department of Radiology, University of Connecticut, Farmington, Conn (J.W.); Department of Radiology and Biomedical Imaging, The Johns Hopkins Hospital, Baltimore, Md (J.W.); and Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass (J.D.)
| | - Michael Chung
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY 10029 (S.M., S.Z.M., D.T., N.V., M.F., M.A.C., C.E., A.J., M.C., A.B.); Complete Radiology Reading Services, Westbury, NY (J.W.); Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (J.W.); Department of Radiology, University of Connecticut, Farmington, Conn (J.W.); Department of Radiology and Biomedical Imaging, The Johns Hopkins Hospital, Baltimore, Md (J.W.); and Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass (J.D.)
| | - Adam Bernheim
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY 10029 (S.M., S.Z.M., D.T., N.V., M.F., M.A.C., C.E., A.J., M.C., A.B.); Complete Radiology Reading Services, Westbury, NY (J.W.); Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (J.W.); Department of Radiology, University of Connecticut, Farmington, Conn (J.W.); Department of Radiology and Biomedical Imaging, The Johns Hopkins Hospital, Baltimore, Md (J.W.); and Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass (J.D.)
| |
Collapse
|
27
|
Voutsinas N, Toussie D, Jacobi A, Bernheim A, Chung M. Incidental CT findings in the lungs in COVID-19 patients presenting with abdominal pain. Clin Imaging 2020; 67:1-4. [PMID: 32492557 PMCID: PMC7255745 DOI: 10.1016/j.clinimag.2020.05.021] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2020] [Revised: 05/09/2020] [Accepted: 05/27/2020] [Indexed: 12/23/2022]
Abstract
As the 2019 novel coronavirus disease (COVID-19) continues to spread, some patients are presenting with abdominal symptoms without respiratory complaints. Our case series documents four patients who presented with abdominal symptoms whose abdominopelvic CT revealed incidental pulmonary parenchymal findings in the imaged lung bases and were subsequently confirmed positive for COVID-19 via laboratory testing. It remains to be seen whether these patients will eventually develop respiratory symptoms. While it is possible that the patients' abdominal complaints are coincidental with CT findings, it is interesting that patients can have such extensive incidental disease in the lungs on CT without respiratory symptoms. Abdominal pain is being more recognized as a potential presenting for COVID-19. Lung findings in COVID-19 patients may not correlate to respiratory symptoms. Noting atypical presentation of COVID-19 allows for earlier quarantine and testing. Early identification can further limit spread of COVID-19.
Collapse
Affiliation(s)
- Nicholas Voutsinas
- Icahn School of Medicine, Department of Diagnostic, Molecular, and Interventional Radiology, 1 Gustave Levy Place, Box 1234, NY, New York 10029, United States of America.
| | - Danielle Toussie
- Icahn School of Medicine, Department of Diagnostic, Molecular, and Interventional Radiology, 1 Gustave Levy Place, Box 1234, NY, New York 10029, United States of America
| | - Adam Jacobi
- Icahn School of Medicine, Department of Diagnostic, Molecular, and Interventional Radiology, 1 Gustave Levy Place, Box 1234, NY, New York 10029, United States of America
| | - Adam Bernheim
- Icahn School of Medicine, Department of Diagnostic, Molecular, and Interventional Radiology, 1 Gustave Levy Place, Box 1234, NY, New York 10029, United States of America
| | - Michael Chung
- Icahn School of Medicine, Department of Diagnostic, Molecular, and Interventional Radiology, 1 Gustave Levy Place, Box 1234, NY, New York 10029, United States of America
| |
Collapse
|
28
|
Toussie D, Voutsinas N, Finkelstein M, Cedillo MA, Manna S, Maron SZ, Jacobi A, Chung M, Bernheim A, Eber C, Concepcion J, Fayad ZA, Gupta YS. Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults with COVID-19. Radiology 2020; 297:E197-E206. [PMID: 32407255 PMCID: PMC7507999 DOI: 10.1148/radiol.2020201754] [Citation(s) in RCA: 215] [Impact Index Per Article: 53.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Background Chest radiography has not been validated for its prognostic utility in evaluating patients with coronavirus disease 2019 (COVID-19). Purpose To analyze the prognostic value of a chest radiograph severity scoring system for younger (nonelderly) patients with COVID-19 at initial presentation to the emergency department (ED); outcomes of interest included hospitalization, intubation, prolonged stay, sepsis, and death. Materials and Methods In this retrospective study, patients between the ages of 21 and 50 years who presented to the ED of an urban multicenter health system from March 10 to March 26, 2020, with COVID-19 confirmation on real-time reverse transcriptase polymerase chain reaction were identified. Each patient's ED chest radiograph was divided into six zones and examined for opacities by two cardiothoracic radiologists, and scores were collated into a total concordant lung zone severity score. Clinical and laboratory variables were collected. Multivariable logistic regression was used to evaluate the relationship between clinical parameters, chest radiograph scores, and patient outcomes. Results The study included 338 patients: 210 men (62%), with median age of 39 years (interquartile range, 31-45 years). After adjustment for demographics and comorbidities, independent predictors of hospital admission (n = 145, 43%) were chest radiograph severity score of 2 or more (odds ratio, 6.2; 95% confidence interval [CI]: 3.5, 11; P < .001) and obesity (odds ratio, 2.4 [95% CI: 1.1, 5.4] or morbid obesity). Among patients who were admitted, a chest radiograph score of 3 or more was an independent predictor of intubation (n = 28) (odds ratio, 4.7; 95% CI: 1.8, 13; P = .002) as was hospital site. No significant difference was found in primary outcomes across race and ethnicity or those with a history of tobacco use, asthma, or diabetes mellitus type II. Conclusion For patients aged 21-50 years with coronavirus disease 2019 presenting to the emergency department, a chest radiograph severity score was predictive of risk for hospital admission and intubation. © RSNA, 2020 Online supplemental material is available for this article.
Collapse
Affiliation(s)
- Danielle Toussie
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| | - Nicholas Voutsinas
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| | - Mark Finkelstein
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| | - Mario A Cedillo
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| | - Sayan Manna
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| | - Samuel Z Maron
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| | - Adam Jacobi
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| | - Michael Chung
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| | - Adam Bernheim
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| | - Corey Eber
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| | - Jose Concepcion
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| | - Zahi A Fayad
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| | - Yogesh Sean Gupta
- From the Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1468 Madison Ave, New York, NY 10029
| |
Collapse
|
29
|
Mei X, Lee HC, Diao K, Huang M, Lin B, Liu C, Xie Z, Ma Y, Robson PM, Chung M, Bernheim A, Mani V, Calcagno C, Li K, Li S, Shan H, Lv J, Zhao T, Xia J, Long Q, Steinberger S, Jacobi A, Deyer T, Luksza M, Liu F, Little BP, Fayad ZA, Yang Y. Artificial intelligence-enabled rapid diagnosis of COVID-19 patients. medRxiv 2020:2020.04.12.20062661. [PMID: 32511559 PMCID: PMC7274240 DOI: 10.1101/2020.04.12.20062661] [Citation(s) in RCA: 49] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
For diagnosis of COVID-19, a SARS-CoV-2 virus-specific reverse transcriptase polymerase chain reaction (RT-PCR) test is routinely used. However, this test can take up to two days to complete, serial testing may be required to rule out the possibility of false negative results, and there is currently a shortage of RT-PCR test kits, underscoring the urgent need for alternative methods for rapid and accurate diagnosis of COVID-19 patients. Chest computed tomography (CT) is a valuable component in the evaluation of patients with suspected SARS-CoV-2 infection. Nevertheless, CT alone may have limited negative predictive value for ruling out SARS-CoV-2 infection, as some patients may have normal radiologic findings at early stages of the disease. In this study, we used artificial intelligence (AI) algorithms to integrate chest CT findings with clinical symptoms, exposure history, and laboratory testing to rapidly diagnose COVID-19 positive patients. Among a total of 905 patients tested by real-time RT-PCR assay and next-generation sequencing RT-PCR, 419 (46.3%) tested positive for SARS-CoV-2. In a test set of 279 patients, the AI system achieved an AUC of 0.92 and had equal sensitivity as compared to a senior thoracic radiologist. The AI system also improved the detection of RT-PCR positive COVID-19 patients who presented with normal CT scans, correctly identifying 17 of 25 (68%) patients, whereas radiologists classified all of these patients as COVID-19 negative. When CT scans and associated clinical history are available, the proposed AI system can help to rapidly diagnose COVID-19 patients.
Collapse
|
30
|
Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, Cui J, Xu W, Yang Y, Fayad ZA, Jacobi A, Li K, Li S, Shan H. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology 2020; 295:202-207. [PMID: 32017661 PMCID: PMC7194022 DOI: 10.1148/radiol.2020200230] [Citation(s) in RCA: 1641] [Impact Index Per Article: 410.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2020] [Revised: 01/31/2020] [Accepted: 02/03/2020] [Indexed: 11/30/2022]
Abstract
In this retrospective case series, chest CT scans of 21 symptomatic patients from China infected with the 2019 novel coronavirus (2019-nCoV) were reviewed, with emphasis on identifying and characterizing the most common findings. Typical CT findings included bilateral pulmonary parenchymal ground-glass and consolidative pulmonary opacities, sometimes with a rounded morphology and a peripheral lung distribution. Notably, lung cavitation, discrete pulmonary nodules, pleural effusions, and lymphadenopathy were absent. Follow-up imaging in a subset of patients during the study time window often demonstrated mild or moderate progression of disease, as manifested by increasing extent and density of lung opacities.
Collapse
Affiliation(s)
- Michael Chung
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Adam Bernheim
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Xueyan Mei
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Ning Zhang
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Mingqian Huang
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Xianjun Zeng
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Jiufa Cui
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Wenjian Xu
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Yang Yang
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Zahi A. Fayad
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Adam Jacobi
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Kunwei Li
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Shaolin Li
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| | - Hong Shan
- From the Department of Diagnostic, Molecular, and Interventional Radiology (M.C., A.B., M.H., Z.A.F., A.J.) and BioMedical Engineering and Imaging Institute (X.M., Y.Y., Z.A.F.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, China (N.Z., X.Z.); Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China (J.C., W.X.); and Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, 52 East Meihua Rd, New Xiangzhou, Zhuhai, Guangdong Province, China, 519000 (K.L., S.L., H.S.)
| |
Collapse
|
31
|
Sahota A, Naidu S, Jacobi A, Giannarelli C, Fayad Z, Mani V. Vaping Safer Than Smoking But Not Without Cardiovascular Risk: A Pet/Mri Study. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Kaufman AE, Pruzan AN, Hsu C, Ramachandran S, Jacobi A, Patel I, Schwocho L, Mercuri MF, Fayad ZA, Mani V. Reproducibility of thrombus volume quantification in multicenter computed tomography pulmonary angiography studies. World J Radiol 2018; 10:124-134. [PMID: 30386497 PMCID: PMC6205841 DOI: 10.4329/wjr.v10.i10.124] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/31/2018] [Revised: 07/27/2018] [Accepted: 08/05/2018] [Indexed: 02/06/2023] Open
Abstract
AIM To evaluate reproducibility of pulmonary embolism (PE) clot volume quantification using computed tomography pulmonary angiogram (CTPA) in a multicenter setting.
METHODS This study was performed using anonymized data in conformance with HIPAA and IRB Regulations (March 2015-November 2016). Anonymized CTPA data was acquired from 23 scanners from 18 imaging centers using each site’s standard PE protocol. Two independent analysts measured PE volumes using a semi-automated region-growing algorithm on an FDA-approved image analysis platform. Total thrombus volume (TTV) was calculated per patient as the primary endpoint. Secondary endpoints were individual thrombus volume (ITV), Qanadli score and modified Qanadli score per patient. Inter- and intra-observer reproducibility were assessed using intra-class correlation coefficient (ICC) and Bland-Altman analysis.
RESULTS Analyst 1 found 72 emboli in the 23 patients with a mean number of emboli of 3.13 per patient with a range of 0-11 emboli per patient. The clot volumes ranged from 0.0041 - 47.34 cm3 (mean +/- SD, 5.93 +/- 10.15cm3). On the second read, analyst 1 found the same number and distribution of emboli with a range of volumes for read 2 from 0.0041 – 45.52 cm3 (mean +/- SD, 5.42 +/- 9.53cm3). Analyst 2 found 73 emboli in the 23 patients with a mean number of emboli of 3.17 per patient with a range of 0-11 emboli per patient. The clot volumes ranged from 0.00459-46.29 cm3 (mean +/- SD, 5.91 +/- 10.06 cm3). Inter- and intra-observer variability measurements indicated excellent reproducibility of the semi-automated method for quantifying PE volume burden. ICC for all endpoints was greater than 0.95 for inter- and intra-observer analysis. Bland-Altman analysis indicated no significant biases.
CONCLUSION Semi-automated region growing algorithm for quantifying PE is reproducible using data from multiple scanners and is a suitable method for image analysis in multicenter clinical trials.
Collapse
Affiliation(s)
- Audrey E Kaufman
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, NY 10029, United States
| | - Alison N Pruzan
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, NY 10029, United States
| | - Ching Hsu
- Daiichi Sankyo Inc., Basking Ridge, NJ 07920, United States
| | - Sarayu Ramachandran
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, NY 10029, United States
| | - Adam Jacobi
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
| | - Indravadan Patel
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Daiichi Sankyo Inc., Basking Ridge, NJ 07920, United States
| | - Lee Schwocho
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Daiichi Sankyo Inc., Basking Ridge, NJ 07920, United States
| | - Michele F Mercuri
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Daiichi Sankyo Inc., Basking Ridge, NJ 07920, United States
| | - Zahi A Fayad
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, NY 10029, United States
| | - Venkatesh Mani
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, NY 10029, United States
| |
Collapse
|
33
|
Girardo S, Träber N, Wagner K, Cojoc G, Herold C, Goswami R, Schlüßler R, Abuhattum S, Taubenberger A, Reichel F, Mokbel D, Herbig M, Schürmann M, Müller P, Heida T, Jacobi A, Ulbricht E, Thiele J, Werner C, Guck J. Standardized microgel beads as elastic cell mechanical probes. J Mater Chem B 2018; 6:6245-6261. [PMID: 32254615 DOI: 10.1039/c8tb01421c] [Citation(s) in RCA: 55] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
Cell mechanical measurements are gaining increasing interest in biological and biomedical studies. However, there are no standardized calibration particles available that permit the cross-comparison of different measurement techniques operating at different stresses and time-scales. Here we present the rational design, production, and comprehensive characterization of poly-acrylamide (PAAm) microgel beads mimicking size and overall mechanics of biological cells. We produced mono-disperse beads at rates of 20-60 kHz by means of a microfluidic droplet generator, where the pre-gel composition was adjusted to tune the beads' elasticity in the range of cell and tissue relevant mechanical properties. We verified bead homogeneity by optical diffraction tomography and Brillouin microscopy. Consistent elastic behavior of microgel beads at different shear rates was confirmed by AFM-enabled nanoindentation and real-time deformability cytometry (RT-DC). The remaining inherent variability in elastic modulus was rationalized using polymer theory and effectively reduced by sorting based on forward-scattering using conventional flow cytometry. Our results show that PAAm microgel beads can be standardized as mechanical probes, to serve not only for validation and calibration of cell mechanical measurements, but also as cell-scale stress sensors.
Collapse
Affiliation(s)
- S Girardo
- Biotechnology Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Tatzberg 47/49, 01307 Dresden, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Kaufman AE, Pruzan AN, Hsu C, Ramachandran S, Jacobi A, Fayad ZA, Mani V. Effect of varying computed tomography acquisition and reconstruction parameters on semi-automated clot volume quantification. World J Radiol 2018; 10:24-29. [PMID: 29599936 PMCID: PMC5872394 DOI: 10.4329/wjr.v10.i3.24] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/09/2018] [Revised: 03/14/2018] [Accepted: 03/20/2018] [Indexed: 02/06/2023] Open
Abstract
AIM To examine effects of computed tomography (CT) image acquisition/reconstruction parameters on clot volume quantification in vitro for research method validation purposes.
METHODS This study was performed in conformance with HIPAA and IRB Regulations (March 2015-November 2016). A ten blood clot phantom was designed and scanned on a dual-energy CT scanner (SOMATOM Force, Siemens Healthcare GmBH, Erlangen, Germany) with varying pitch, iterative reconstruction, energy level and slice thickness. A range of clot and tube sizes were used in an attempt to replicate in vivo emboli found within central and segmental branches of the pulmonary arteries in patients with pulmonary emboli. Clot volume was the measured parameter and was analyzed by a single image analyst using a semi-automated region growing algorithm implemented in the FDA-approved Siemens syngo.via image analysis platform. Mixed model analysis was performed on the data.
RESULTS On the acquisition side, the continuous factor of energy showed no statistically significant effect on absolute clot volume quantification (P = 0.9898). On the other hand, when considering the fixed factor of pitch, there were statistically significant differences in clot volume quantification (P < 0.0001). On the reconstruction side, with the continuous factor of reconstruction slice thickness no statistically significant effect on absolute clot volume quantification was demonstrated (P = 0.4500). Also on the reconstruction side, with the fixed factor of using iterative reconstructions there was also no statistically significant effect on absolute clot volume quantification (P = 0.3011). In addition, there was excellent R2 correlation between the scale-measured mass of the clots both with respect to the CT measured volumes and with respect to volumes measure by the water displacement method.
CONCLUSION Aside from varying pitch, changing CT acquisition parameters and using iterative reconstructions had no significant impact on clot volume quantification with a semi-automated region growing algorithm.
Collapse
Affiliation(s)
- Audrey E Kaufman
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, NY 10029, United States
| | - Alison N Pruzan
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, NY 10029, United States
| | - Ching Hsu
- Daiichi Sankyo Inc., Basking Ridge, NJ 07920, United States
| | - Sarayu Ramachandran
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, NY 10029, United States
| | - Adam Jacobi
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
| | - Zahi A Fayad
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, NY 10029, United States
| | - Venkatesh Mani
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States
- Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, NY 10029, United States
| |
Collapse
|
35
|
Goepel L, Jacobi A, Augustin M, Radtke MA. Rapid improvement of psoriasis in a patient with lung cancer after treatment with erlotinib. J Eur Acad Dermatol Venereol 2018; 32:e311-e313. [PMID: 29430731 DOI: 10.1111/jdv.14862] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- L Goepel
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.,Department of Dermatology, Elbe Kliniken Buxtehude, Am Krankenhaus 1, 21614, Buxtehude, Germany
| | - A Jacobi
- Practice for Dermatology, Dr. Kasche, Langelohstraße 158, 22549, Hamburg, Germany
| | - M Augustin
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany
| | - M A Radtke
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany
| |
Collapse
|
36
|
Mössner R, Wilsmann-Theis D, Oji V, Gkogkolou P, Löhr S, Schulz P, Körber A, Prinz JC, Renner R, Schäkel K, Vogelsang L, Peters KP, Philipp S, Reich K, Ständer H, Jacobi A, Weyergraf A, Kingo K, Kõks S, Gerdes S, Steinz K, Schill T, Griewank KG, Müller M, Frey S, Ebertsch L, Uebe S, Sticherling M, Sticht H, Hüffmeier U. The genetic basis for most patients with pustular skin disease remains elusive. Br J Dermatol 2018; 178:740-748. [PMID: 28887889 DOI: 10.1111/bjd.15867] [Citation(s) in RCA: 74] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/27/2017] [Indexed: 12/27/2022]
Abstract
BACKGROUND Rare variants in the genes IL36RN, CARD14 and AP1S3 have been identified to cause or contribute to pustular skin diseases, primarily generalized pustular psoriasis (GPP). OBJECTIVES To better understand the disease relevance of these genes, we screened our cohorts of patients with pustular skin diseases [primarily GPP and palmoplantar pustular psoriasis (PPP)] for coding changes in these three genes. Carriers of single heterozygous IL36RN mutations were screened for a second mutation in IL36RN. METHODS Coding exons of IL36RN, CARD14 and AP1S3 were sequenced in 67 patients - 61 with GPP, two with acute generalized exanthematous pustulosis and four with acrodermatitis continua of Hallopeau. We screened IL36RN and AP1S3 for intragenic copy-number variants and 258 patients with PPP for coding changes in AP1S3. Eleven heterozygous IL36RN mutations carriers were analysed for a second noncoding IL36RN mutation. Genotype-phenotype correlations in carriers/noncarriers of IL36RN mutations were assessed within the GPP cohort. RESULTS The majority of patients (GPP, 64%) did not carry rare variants in any of the three genes. Biallelic and monoallelic IL36RN mutations were identified in 15 and five patients with GPP, respectively. Noncoding rare IL36RN variants were not identified in heterozygous carriers. The only significant genotype-phenotype correlation observed for IL36RN mutation carriers was early age at disease onset. Additional rare CARD14 or AP1S3 variants were identified in 15% of IL36RN mutation carriers. CONCLUSIONS The identification of IL36RN mutation carriers harbouring additional rare variants in CARD14 or AP1S3 indicates a more complex mode of inheritance of pustular psoriasis. Our results suggest that, in heterozygous IL36RN mutation carriers, there are additional disease-causing genetic factors outside IL36RN.
Collapse
Affiliation(s)
- R Mössner
- Department of Dermatology, Georg-August-University Göttingen, Göttingen, Germany
| | - D Wilsmann-Theis
- Department of Dermatology and Allergy, University Bonn, Bonn, Germany
| | - V Oji
- Department of Dermatology, University Münster, Münster, Germany
| | - P Gkogkolou
- Department of Dermatology, University Münster, Münster, Germany
| | - S Löhr
- Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - P Schulz
- Department of Dermatology, Fachklinik Bad Bentheim, Bad Bentheim, Germany
| | - A Körber
- Department of Dermatology, University of Essen, Essen, Germany
| | - J C Prinz
- Department of Dermatology and Allergology, Ludwig-Maximilian University Munich, Munich, Germany
| | - R Renner
- Department of Dermatology, University Hospital Erlangen, Erlangen, Germany
| | - K Schäkel
- Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany
| | - L Vogelsang
- Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany
| | - K-P Peters
- Department of Dermatology and Allergology, Hospital Bayreuth, Bayreuth, Germany
| | - S Philipp
- Department of Dermatology and Allergy, Charité Universitätsmedizin Berlin, Berlin, Germany
| | - K Reich
- Dermatologikum Hamburg, Hamburg, Germany
| | - H Ständer
- Department of Dermatology, Klinikum Dortmund, Dortmund, Germany
| | - A Jacobi
- Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - A Weyergraf
- Department of Dermatology, Fachklinik Bad Bentheim, Bad Bentheim, Germany
| | - K Kingo
- Department of Dermatology, Dermatology Clinic, University of Tartu, Tartu, Estonia
| | - S Kõks
- Department of Pathophysiology, University of Tartu, Tartu, Estonia
| | - S Gerdes
- Department of Dermatology, University of Kiel, Kiel, Germany
| | - K Steinz
- Department of Dermatology, University of Kiel, Kiel, Germany
| | - T Schill
- Department of Dermatology and Allergy, University Bonn, Bonn, Germany
| | - K G Griewank
- Department of Dermatology, University of Essen, Essen, Germany
| | - M Müller
- Institute of Occcupational, Social and Environmental Medicine, Georg-August-University Göttingen, Göttingen, Germany
| | - S Frey
- Department of Internal Medicine 3 - Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany
| | - L Ebertsch
- Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - S Uebe
- Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - M Sticherling
- Department of Dermatology, University Hospital Erlangen, Erlangen, Germany
| | - H Sticht
- Bioinformatics, Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - U Hüffmeier
- Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| |
Collapse
|
37
|
Zander N, Schäfer I, Radtke M, Jacobi A, Heigel H, Augustin M. Dermatological comorbidity in psoriasis: results from a large-scale cohort of employees. Arch Dermatol Res 2017; 309:349-356. [DOI: 10.1007/s00403-017-1741-4] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2016] [Revised: 03/02/2017] [Accepted: 04/04/2017] [Indexed: 12/25/2022]
|
38
|
Abstract
Extraskeletal myxoid chondrosarcomas (EMC) are a rare entity of soft tissue tumors that have slow growth with metastatic potential. We discuss here a case of EMC presenting with right upper extremity pain and hemoptysis. Computed tomography scans chest showed diffuse metastatic numerous lung nodules bilaterally. Biopsy confirmed the diagnosis of the tumor. Chemotherapy was a bigger challenge for our patient due to sparse research and data in the literature about the disease.
Collapse
Affiliation(s)
| | - Neha Khanna
- Department of Cardiovascular Imaging, Mount Sinai Hospital, New York, USA
| | - Adam Jacobi
- Department of Radiology, Mount Sinai Hospital, New York, USA
| |
Collapse
|
39
|
Swaan CM, Öry A, Schol L, Jacobi A, Richardus JH, Timen A. Ebola preparedness: the need for co-ordination overarching the public health and curative sector. Eur J Public Health 2016. [DOI: 10.1093/eurpub/ckw164.058] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Otto O, Rosendahl P, Golfier S, Mietke A, Herbig M, Jacobi A, Topfner N, Herold C, Klaue D, Girardo S, Winzi M, Fischer-Friedrich E, Guck J. Real-time deformability cytometry as a label-free indicator of cell function. Annu Int Conf IEEE Eng Med Biol Soc 2016; 2015:1861-4. [PMID: 26736644 DOI: 10.1109/embc.2015.7318744] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
The mechanical properties of cells are known to be a label-free, inherent marker of biological function in health and disease. Wide-spread utilization has so far been impeded by the lack of a convenient measurement technique with sufficient throughput. To address this unmet need, we have recently introduced real-time deformability cytometry (RT-DC) for continuous mechanical single-cell classification of heterogeneous cell populations at rates of several hundred cells per second. Cells are driven through the constriction zone of a microfluidic chip leading to cell deformations due to hydrodynamic stresses only. Our custom-built image processing software performs image acquisition, image analysis and data storage on the fly. The ensuing deformations can be quantified and an analytical model enables the derivation of cell material properties. Performing RT-DC we highlight its potential to identify rare objects in heterogeneous suspensions and to track drug-induced changes in cells. In summary, RT-DC enables marker-free, quantitative phenotyping of heterogeneous cell populations with a throughput comparable to standard flow cytometry.
Collapse
|
41
|
Jacobi A, Eber C, Weinberger A, Friedman SN. Bilateral Pneumothoraces after Unilateral Lung Biopsy. A Case of "Buffalo Chest"? Am J Respir Crit Care Med 2016; 193:e36. [PMID: 26799333 DOI: 10.1164/rccm.201509-1850im] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- Adam Jacobi
- 1 Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York; and
| | - Corey Eber
- 1 Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York; and
| | - Andrew Weinberger
- 2 Sackler School of Medicine, Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
| | - Saul N Friedman
- 2 Sackler School of Medicine, Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
| |
Collapse
|
42
|
Radtke MA, Schäfer I, Glaeske G, Jacobi A, Augustin M. Prevalence and comorbidities in adults with psoriasis compared to atopic eczema. J Eur Acad Dermatol Venereol 2016; 31:151-157. [PMID: 27521212 DOI: 10.1111/jdv.13813] [Citation(s) in RCA: 59] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2015] [Accepted: 05/02/2016] [Indexed: 12/12/2022]
Abstract
BACKGROUND Most data suggesting an association between psoriasis and cardiovascular disease (CVD) have come from specialized populations at either low or high risk of CVD. Atopic dermatitis (AD) has been associated with a number of modifiable risk factors, particularly obesity. There has been a recent controversy on the suggestion that associations with comorbidities in psoriasis may be due to overreporting or biased by disease severity and therefore not necessarily representative of the general psoriasis population. OBJECTIVES To evaluate the prevalence of AD and psoriasis and to compare the prevalence rates of comorbidities based on a large sample of health insurance data. METHODS Data were collected from a database of non-selected individuals from a German statutory health insurance organization that covers all geographic regions. Individuals identified by International Classification of Diseases (ICD)-10 codes applied to all outpatient and inpatient visits in the year 2009. Comorbidities were evaluated by ICD-10 diagnoses. RESULTS The database consisted of 1 642 852 members of a German statutory health insurance. Of 1 349 671 data sets analyzed, 37 456 patients ≥18 years were diagnosed with psoriasis (prevalence 2.78%), and 48 140 patients ≥18 years of age were diagnosed with AD, equivalent to a prevalence of 3.67%. Patients with psoriasis showed increased rates of comorbidities in all age groups. Comorbidities related to the metabolic syndrome including arterial hypertension [prevalence ratio (PR), 1.94; 95% confidence interval (CI), 1.90-1.98], hyperlipidaemia (PR, 1.77; 95% CI, 1.73-1.81), obesity (PR, 1.74; 95% CI, 1.69-1.79) and diabetes mellitus (PR, 1.88; 95% CI, 1.83-1.94) were significantly more common among patients with psoriasis compared to AD. CONCLUSIONS Diseases forming part of the metabolic syndrome showed significant lower prevalence rates in patients with AD than in patients with psoriasis. Within the limitations of secondary healthcare data, our study disproves the suggestion that associations with comorbidities in psoriasis may be biased by a higher degree of severity or overreporting.
Collapse
Affiliation(s)
- M A Radtke
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - I Schäfer
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - G Glaeske
- Centre for Social Policy Research, University of Bremen, Bremen, Germany
| | - A Jacobi
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - M Augustin
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| |
Collapse
|
43
|
Radtke M, Langenbruch A, Jacobi A, Schaarschmidt ML, Augustin M. Patient benefits in the treatment of psoriasis: long-term outcomes in German routine care 2007-2014. J Eur Acad Dermatol Venereol 2016; 30:1829-1833. [DOI: 10.1111/jdv.13764] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2015] [Accepted: 03/30/2016] [Indexed: 12/11/2022]
Affiliation(s)
- M.A. Radtke
- Institute for Health Services Research in Dermatology and Nursing (IVDP); University Medical Center Hamburg-Eppendorf (UKE); Hamburg Germany
| | - A. Langenbruch
- Institute for Health Services Research in Dermatology and Nursing (IVDP); University Medical Center Hamburg-Eppendorf (UKE); Hamburg Germany
| | - A. Jacobi
- Institute for Health Services Research in Dermatology and Nursing (IVDP); University Medical Center Hamburg-Eppendorf (UKE); Hamburg Germany
| | - M.-L. Schaarschmidt
- Institute for Health Services Research in Dermatology and Nursing (IVDP); University Medical Center Hamburg-Eppendorf (UKE); Hamburg Germany
| | - M. Augustin
- Institute for Health Services Research in Dermatology and Nursing (IVDP); University Medical Center Hamburg-Eppendorf (UKE); Hamburg Germany
| |
Collapse
|
44
|
Zänker M, Schwill U, Bielecke C, Jacobi A, Sokoll K, Zeidler G, Scheibert A, Reutermann P, Bohl-Bühler M, Engel J, Prothmann U, Backhaus M. FRI0584 The Vicious Circle of Educational Level, Rheumatoid Arthritis, and Risk of Poverty - Results of A Cross-Sectional Multicenter Study in Germany. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3316] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
45
|
Agarwal C, Goel S, Jacobi A, Love B, Sanz J. CT imaging of post-myocardial infarction ventricular septal defect with a contained rupture/pseudoaneurysm. Indian Heart J 2016; 67 Suppl 3:S107-9. [PMID: 26995413 PMCID: PMC4799005 DOI: 10.1016/j.ihj.2015.07.035] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2014] [Revised: 07/08/2015] [Accepted: 07/20/2015] [Indexed: 12/02/2022] Open
Abstract
This is a CT imaging study of a 63-year-old female who presented to our center with ST segment elevation MI and was found to have life threatening post-MI ventricular septal defect with associated pseudoaneurysm, which was detected on cardiac CTA. The patient refused surgical management and had a successful percutaneous VSD repair.
Collapse
Affiliation(s)
- Chirag Agarwal
- Icahn School of Medicine, Mount Sinai Medical Center, NY, United States
| | - Sunny Goel
- Maimonides Medical Center, Brooklyn, NY, United States.
| | - Adam Jacobi
- Icahn School of Medicine, Mount Sinai Medical Center, NY, United States
| | - Barry Love
- Icahn School of Medicine, Mount Sinai Medical Center, NY, United States
| | - Javier Sanz
- Icahn School of Medicine, Mount Sinai Medical Center, NY, United States
| |
Collapse
|
46
|
Margolies L, Salvatore M, Eber C, Jacobi A, Lee IJ, Liang M, Tang W, Xu D, Zhao S, Kale M, Wisnivesky J, Henschke CI, Yankelevitz D. The general radiologist’s role in breast cancer risk assessment: breast density measurement on chest CT. Clin Imaging 2015. [DOI: 10.1016/j.clinimag.2015.05.010] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
47
|
Willeke P, Schlüter B, Sauerland C, Becker H, Reuter S, Jacobi A, Schotte H. Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis. PLoS One 2015; 10:e0137196. [PMID: 26339905 PMCID: PMC4560371 DOI: 10.1371/journal.pone.0137196] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2015] [Accepted: 07/22/2015] [Indexed: 01/09/2023] Open
Abstract
Objective To investigate the association of farm exposure and the development of ANCA-associated vasculitis (AAV). Methods One hundred eighty-nine well defined patients with AAV (n = 119 with granulomatosis with polyangiitis [GPA], n = 48 with microscopic polyangiitis [MPA], n = 22 patients with eosinophilic granulomatosis with polyangiitis [EGPA]) and 190 controls (n = 119 patients with rheumatoid arthritis, n = 71 with large vessel vasculitis) were interrogated using a structured questionnaire. Factors investigated were occupation, farm exposure, contact to different livestock, participation in harvesting, residence next to a farm, MRSA status, and contact to domestic pets at disease onset or ever before. The odds ratio (OR) and 95% confidence interval [95%CI] were calculated for each item. Results Univariate analysis revealed a strong association of AAV with regular farm exposure; OR 3.44 [95%CI 1.43–8.27]. AAV was also associated with regular contact to cattle 4.30 (1.43–8.27), pigs 2.75 (1.12–6.75) and MRSA carriage 3.38 (1.11–10.3). This association was stronger in the subgroup of GPA patients. OR in this group for farm exposure was 4.97; [2.02–12.2], for cattle 6.71 [95% CI 2.19–20.7], for pigs 4.34 [1.75–10.9], and MRSA carriage 5.06 [1.62–15.8]). There was no significant association of MPA or EGPA with these parameters. Conclusion A significant association between farm exposure or farm animal exposure and AAV especially in the subgroup of patients with GPA has been identified. This suggests that these entities are distinct and have different triggers for the immune process.
Collapse
Affiliation(s)
- P. Willeke
- Department of Medicine D, Section of Rheumatology and Clinical Immunology, University Hospital Münster, Münster, Germany
- * E-mail:
| | - B. Schlüter
- Centre for Laboratory Medicine, University Hospital Münster, Münster, Germany
| | - C. Sauerland
- Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany
| | - H. Becker
- Department of Medicine D, Section of Rheumatology and Clinical Immunology, University Hospital Münster, Münster, Germany
| | - S. Reuter
- Department of Medicine D, Section of Rheumatology and Clinical Immunology, University Hospital Münster, Münster, Germany
| | - A. Jacobi
- Division of Rheumatology and Clinical Immunology, Brandenburg Medical School, Neuruppin, Germany
| | - H. Schotte
- Department of Medicine D, Section of Rheumatology and Clinical Immunology, University Hospital Münster, Münster, Germany
| |
Collapse
|
48
|
Affiliation(s)
- Carlos A Gonzalez Lengua
- Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, New York, NY 10029, USA
| | - Adam Jacobi
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Harvey S Hecht
- Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, New York, NY 10029, USA
| |
Collapse
|
49
|
Jacobi A, Kis A, Radtke M, Augustin J, Glaeske G, Schaefer I, Augustin M. Regionale Unterschiede in der Versorgung der juvenilen Psoriasis in Deutschland. Akt Dermatol 2015. [DOI: 10.1055/s-0034-1392778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- A. Jacobi
- Competenzzentrum Versorgungsforschung in der Dermatologie (CVderm), Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP), Universitätsklinikum Hamburg-Eppendorf, Hamburg
| | - A. Kis
- Competenzzentrum Versorgungsforschung in der Dermatologie (CVderm), Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP), Universitätsklinikum Hamburg-Eppendorf, Hamburg
| | - M. Radtke
- Competenzzentrum Versorgungsforschung in der Dermatologie (CVderm), Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP), Universitätsklinikum Hamburg-Eppendorf, Hamburg
| | - J. Augustin
- Competenzzentrum Versorgungsforschung in der Dermatologie (CVderm), Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP), Universitätsklinikum Hamburg-Eppendorf, Hamburg
| | - G. Glaeske
- Zentrum für Sozialpolitik, Universität Bremen, Bremen
| | - I. Schaefer
- Competenzzentrum Versorgungsforschung in der Dermatologie (CVderm), Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP), Universitätsklinikum Hamburg-Eppendorf, Hamburg
| | - M. Augustin
- Competenzzentrum Versorgungsforschung in der Dermatologie (CVderm), Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP), Universitätsklinikum Hamburg-Eppendorf, Hamburg
| |
Collapse
|
50
|
Hillmann A, Jung E, Engbers A, Reinhardt M, Wardemann H, Rieger M, Pap T, Jacobi A. A2.13 DNA-antibody complexes are internalised by podocytes. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-207259.48] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|